KR20120140603A - New material for transporting electron and organic electroluminescent device using the same - Google Patents
New material for transporting electron and organic electroluminescent device using the same Download PDFInfo
- Publication number
- KR20120140603A KR20120140603A KR1020120035373A KR20120035373A KR20120140603A KR 20120140603 A KR20120140603 A KR 20120140603A KR 1020120035373 A KR1020120035373 A KR 1020120035373A KR 20120035373 A KR20120035373 A KR 20120035373A KR 20120140603 A KR20120140603 A KR 20120140603A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- alkyl
- mmol
- aryl
- heteroaryl
- Prior art date
Links
- LOFFYRPAYGSDJM-UHFFFAOYSA-N CC1(C)c2cc(-c3cc(-c4ccc(cc5)c6c4ccc4c6c5ccc4)nc(-c4cccc(-c5nc6cccnc6[o]5)c4)n3)ccc2-c2c1cccc2 Chemical compound CC1(C)c2cc(-c3cc(-c4ccc(cc5)c6c4ccc4c6c5ccc4)nc(-c4cccc(-c5nc6cccnc6[o]5)c4)n3)ccc2-c2c1cccc2 LOFFYRPAYGSDJM-UHFFFAOYSA-N 0.000 description 2
- NIFKPMOGJLNKIU-UHFFFAOYSA-N CC1(C)c2cc(-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)nc(C)c3)ccc2-c2c1cccc2 Chemical compound CC1(C)c2cc(-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)nc(C)c3)ccc2-c2c1cccc2 NIFKPMOGJLNKIU-UHFFFAOYSA-N 0.000 description 2
- DVNUPSFFJXDTSB-UHFFFAOYSA-N Bc1cc(-c2nc3cccnc3[s]2)ccc1 Chemical compound Bc1cc(-c2nc3cccnc3[s]2)ccc1 DVNUPSFFJXDTSB-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- APGRKSKKDARQMN-UHFFFAOYSA-N CC(C)(c1c2)c(cccc3)c3-c1ccc2-c1ccnc(-c(cc2)ccc2-c2cc3ncn[n]3cc2)n1 Chemical compound CC(C)(c1c2)c(cccc3)c3-c1ccc2-c1ccnc(-c(cc2)ccc2-c2cc3ncn[n]3cc2)n1 APGRKSKKDARQMN-UHFFFAOYSA-N 0.000 description 1
- DMDPAJOXRYGXCB-UHFFFAOYSA-N CC1(C)c(cc(B(O)O)cc2)c2-c2ccccc12 Chemical compound CC1(C)c(cc(B(O)O)cc2)c2-c2ccccc12 DMDPAJOXRYGXCB-UHFFFAOYSA-N 0.000 description 1
- YTOXMNBCOOZUKI-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3cc(-c4cc(cccc5)c5c5ccccc45)nc(-c4cccc(-c5nc6cccnc6[s]5)c4)n3)c2-c2c1cccc2 Chemical compound CC1(C)c(cc(cc2)-c3cc(-c4cc(cccc5)c5c5ccccc45)nc(-c4cccc(-c5nc6cccnc6[s]5)c4)n3)c2-c2c1cccc2 YTOXMNBCOOZUKI-UHFFFAOYSA-N 0.000 description 1
- BAOHKDGWVVRDGK-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3cc(-c4cc5ccccc5c5ccccc45)nc(Cl)n3)c2-c2c1cccc2 Chemical compound CC1(C)c(cc(cc2)-c3cc(-c4cc5ccccc5c5ccccc45)nc(Cl)n3)c2-c2c1cccc2 BAOHKDGWVVRDGK-UHFFFAOYSA-N 0.000 description 1
- OFDLXMNVZTWMIY-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc(cccn6)c6[o]5)c4)nc(-c(cc4)cc(C5(C)C)c4-c4c5cccc4)c3)c2-c2c1cccc2 Chemical compound CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc(cccn6)c6[o]5)c4)nc(-c(cc4)cc(C5(C)C)c4-c4c5cccc4)c3)c2-c2c1cccc2 OFDLXMNVZTWMIY-UHFFFAOYSA-N 0.000 description 1
- JDYRNXGRQVDACL-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc(cccn6)c6[o]5)c4)nc(-c4ccccc4)c3)c2-c2c1cccc2 Chemical compound CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc(cccn6)c6[o]5)c4)nc(-c4ccccc4)c3)c2-c2c1cccc2 JDYRNXGRQVDACL-UHFFFAOYSA-N 0.000 description 1
- NZWQPOVKUDGMPI-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)nc(-c(cc4)ccc4-c4cc(-c(cc5)cc(c6c7cccc6)c5cc7-c5nc(-c6cccc(-c7nc8cccnc8[o]7)c6)ncc5)cc5c4cccc5)c3)c2-c2ccccc12 Chemical compound CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)nc(-c(cc4)ccc4-c4cc(-c(cc5)cc(c6c7cccc6)c5cc7-c5nc(-c6cccc(-c7nc8cccnc8[o]7)c6)ncc5)cc5c4cccc5)c3)c2-c2ccccc12 NZWQPOVKUDGMPI-UHFFFAOYSA-N 0.000 description 1
- MGRPXOPXPZSAJU-UHFFFAOYSA-N CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)ncc3)c2-c2c1cccc2 Chemical compound CC1(C)c(cc(cc2)-c3nc(-c4cccc(-c5nc6cccnc6[o]5)c4)ncc3)c2-c2c1cccc2 MGRPXOPXPZSAJU-UHFFFAOYSA-N 0.000 description 1
- ANKCEZUUMRGBRI-UHFFFAOYSA-N CC1(C)c2cc(-c3cc(C)nc(-c(cc4)ccc4-c4cc5ncn[n]5cc4)n3)ccc2-c2ccccc12 Chemical compound CC1(C)c2cc(-c3cc(C)nc(-c(cc4)ccc4-c4cc5ncn[n]5cc4)n3)ccc2-c2ccccc12 ANKCEZUUMRGBRI-UHFFFAOYSA-N 0.000 description 1
- PKXGFNLDOYHNBC-UHFFFAOYSA-N CC1(C)c2cc(-c3cc(Cl)nc(Cl)n3)ccc2-c2c1cccc2 Chemical compound CC1(C)c2cc(-c3cc(Cl)nc(Cl)n3)ccc2-c2c1cccc2 PKXGFNLDOYHNBC-UHFFFAOYSA-N 0.000 description 1
- VEPALRARELMAEW-UHFFFAOYSA-N CC1(C)c2cc(-c3nc(-c4cccc(-c5nc6cccnc6[s]5)c4)nc(-c(cc4)ccc4-c4cccc5c4cccc5)c3)ccc2-c2c1cccc2 Chemical compound CC1(C)c2cc(-c3nc(-c4cccc(-c5nc6cccnc6[s]5)c4)nc(-c(cc4)ccc4-c4cccc5c4cccc5)c3)ccc2-c2c1cccc2 VEPALRARELMAEW-UHFFFAOYSA-N 0.000 description 1
- HXEDGHUDTQQJDK-UHFFFAOYSA-N Cc1cc(-c2cccc3c2cccc3)nc(-c(cc2)ccc2C(C=C2)=CC3N2N=CN3C)n1 Chemical compound Cc1cc(-c2cccc3c2cccc3)nc(-c(cc2)ccc2C(C=C2)=CC3N2N=CN3C)n1 HXEDGHUDTQQJDK-UHFFFAOYSA-N 0.000 description 1
- VUIMAOUYZVMVRF-UHFFFAOYSA-N Cc1cc(-c2ccccc2)nc(-c2cccc(-c3nc4cccnc4[o]3)c2)n1 Chemical compound Cc1cc(-c2ccccc2)nc(-c2cccc(-c3nc4cccnc4[o]3)c2)n1 VUIMAOUYZVMVRF-UHFFFAOYSA-N 0.000 description 1
- DPVIABCMTHHTGB-UHFFFAOYSA-N Clc1cc(Cl)nc(Cl)n1 Chemical compound Clc1cc(Cl)nc(Cl)n1 DPVIABCMTHHTGB-UHFFFAOYSA-N 0.000 description 1
- JCDAUYWOHOLVMH-UHFFFAOYSA-N OB(c1cc2ccccc2c2ccccc12)O Chemical compound OB(c1cc2ccccc2c2ccccc12)O JCDAUYWOHOLVMH-UHFFFAOYSA-N 0.000 description 1
- XUMORWZWEXHXPS-UHFFFAOYSA-N c(cc1)cc2c1c(-c1c(cccc3)c3c(-c3cc(-c4nc5cccnc5[s]4)ccc3)c3c1cccc3)ccc2 Chemical compound c(cc1)cc2c1c(-c1c(cccc3)c3c(-c3cc(-c4nc5cccnc5[s]4)ccc3)c3c1cccc3)ccc2 XUMORWZWEXHXPS-UHFFFAOYSA-N 0.000 description 1
- NSKDXSMVCAQCOB-UHFFFAOYSA-N c(cc1)cc2c1c(cccc1)c1c(-c1c(cccc3)c3c(-c3cc(-c4nc5cccnc5[s]4)ccc3)c3c1cccc3)c2 Chemical compound c(cc1)cc2c1c(cccc1)c1c(-c1c(cccc3)c3c(-c3cc(-c4nc5cccnc5[s]4)ccc3)c3c1cccc3)c2 NSKDXSMVCAQCOB-UHFFFAOYSA-N 0.000 description 1
- VNKKWBZYWMJYIJ-UHFFFAOYSA-N c(cc1)ccc1-c(c1ccccc11)ccc1-c1c(cccc2)c2c(-c2cc(-c3nc4cccnc4[s]3)ccc2)c2c1cccc2 Chemical compound c(cc1)ccc1-c(c1ccccc11)ccc1-c1c(cccc2)c2c(-c2cc(-c3nc4cccnc4[s]3)ccc2)c2c1cccc2 VNKKWBZYWMJYIJ-UHFFFAOYSA-N 0.000 description 1
- LDXKPZSMLNHBFA-UHFFFAOYSA-N c(cn1)cc2c1[o]c(-c1cc(-c3nccc(-c4ccc(cc5)c6c4ccc4c6c5ccc4)n3)ccc1)n2 Chemical compound c(cn1)cc2c1[o]c(-c1cc(-c3nccc(-c4ccc(cc5)c6c4ccc4c6c5ccc4)n3)ccc1)n2 LDXKPZSMLNHBFA-UHFFFAOYSA-N 0.000 description 1
- ZQVBCVITWLNHCB-UHFFFAOYSA-N c1ccc(cc(cc2)-c3c(cccc4)c4c(-c4cc(-c5nc6cccnc6[s]5)ccc4)c4c3cccc4)c2c1 Chemical compound c1ccc(cc(cc2)-c3c(cccc4)c4c(-c4cc(-c5nc6cccnc6[s]5)ccc4)c4c3cccc4)c2c1 ZQVBCVITWLNHCB-UHFFFAOYSA-N 0.000 description 1
- XSMVEWBKMDGZRB-UHFFFAOYSA-N c1ccc2c(-c3c(cccc4)c4c(-c4cc(-c5nc6cccnc6[s]5)ccc4)c4c3cccc4)c(cccc3)c3cc2c1 Chemical compound c1ccc2c(-c3c(cccc4)c4c(-c4cc(-c5nc6cccnc6[s]5)ccc4)c4c3cccc4)c(cccc3)c3cc2c1 XSMVEWBKMDGZRB-UHFFFAOYSA-N 0.000 description 1
- ZFQKCWWSDKKUTR-UHFFFAOYSA-N c1n[n](cc(cc2)-c3cc4c(-c5cc6ccccc6cc5)c(ccc(-c5cnc6[s]c(-c7cc(-c(cc8)cc9c8c(-c8cc(cccc%10)c%10cc8)c(cccc8)c8c9-c8cc9ccccc9cc8)ccc7)nc6c5)c5)c5c(-c5cc(cccc6)c6cc5)c4cc3)c2n1 Chemical compound c1n[n](cc(cc2)-c3cc4c(-c5cc6ccccc6cc5)c(ccc(-c5cnc6[s]c(-c7cc(-c(cc8)cc9c8c(-c8cc(cccc%10)c%10cc8)c(cccc8)c8c9-c8cc9ccccc9cc8)ccc7)nc6c5)c5)c5c(-c5cc(cccc6)c6cc5)c4cc3)c2n1 ZFQKCWWSDKKUTR-UHFFFAOYSA-N 0.000 description 1
- CAQZPKPHOHXPMW-UHFFFAOYSA-N c1n[n](ccc(-c(cc2)ccc2-c2nccc(-c3cccc4c3cccc4)n2)c2)c2n1 Chemical compound c1n[n](ccc(-c(cc2)ccc2-c2nccc(-c3cccc4c3cccc4)n2)c2)c2n1 CAQZPKPHOHXPMW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
Abstract
Description
본 발명은 신규한 전자 수송 물질 및 이를 이용한 유기 발광 소자에 관한 것이다.The present invention relates to a novel electron transport material and an organic light emitting device using the same.
유기 발광 소자는 전자 주입 전극(음극) 과 정공 주입 전극(양극) 사이에 형성된 유기막에 전하를 주입하면 전자와 정공이 쌍을 이룬 후 소멸하면서 빛을 내는 소자이다. 플라스틱 같은 휠 수 있는(flexible) 투명 기판 위에도 소자를 형성할 수 있을 뿐 아니라, 플라즈마 디스플레이 패널(Plasma Display Panel)이나 무기 EL 디스플레이에 비해 낮은 전압에서 (10V이하) 구동이 가능하고, 또한 전력 소모가 비교적 적으며, 색감이 뛰어나다는 장점이 있다. An organic light emitting device is a device that emits light by dissipating electrons and holes after pairing when an electric charge is injected into an organic film formed between an electron injection electrode (cathode) and a hole injection electrode (anode). The device can be formed on a flexible transparent substrate such as plastic, and can be driven at a lower voltage (less than 10V) compared to a plasma display panel or an inorganic EL display, and also consumes power. It is relatively small and has the advantage of excellent color.
일반적인 유기 전기발광 소자의 구조는 기판, 양극, 정공을 양극으로부터 받아들이는 정공 주입층, 정공을 이송하는 정공 수송층, 정공과 전자가 결합하여 빛을 내는 발광층, 전자를 음극으로부터 받아들여 발광층으로 전달하는 전자 수송층, 및 음극으로 구성되어 있다. 경우에 따라서는 별도의 발광층 없이 전자 수송층이나 정공 수송층에 소량의 형광 또는 인광성 염료를 도핑하여 발광층을 구성할 수도 있으며, 고분자를 사용할 경우에는 일반적으로 정공 수송층과 발광층, 및 전자 수송층의 역할을 하나의 고분자가 동시에 수행할 수 있다. 두 전극 사이의 유기물 박막층들은 진공증착법 또는 스핀코팅, 잉크젯프린팅, 롤코팅 등의 방법으로 형성되며, 음극으로부터 전자의 효율적인 주입을 위해 별도의 전자 주입층을 삽입하는 경우도 있다.The structure of a general organic electroluminescent device includes a substrate, an anode, a hole injection layer that receives holes from an anode, a hole transport layer that transports holes, a light emitting layer that combines holes and electrons to emit light, and receives electrons from a cathode and transfers them to the light emitting layer. It consists of an electron carrying layer and a cathode. In some cases, a light emitting layer may be formed by doping a small amount of fluorescent or phosphorescent dye into an electron transporting layer or a hole transporting layer without a separate light emitting layer, and in the case of using a polymer, it generally serves as a hole transporting layer, a light emitting layer, and an electron transporting layer. The polymer can be carried out simultaneously. The organic thin film layers between the two electrodes are formed by vacuum deposition or spin coating, inkjet printing, roll coating, or the like, and a separate electron injection layer may be inserted to efficiently inject electrons from the cathode.
전극과 유기물사이의 계면을 안정화시키거나, 또는 유기 물질의 경우 정공과 전자의 이동속도가 크게 차이가 나므로 적절한 정공 수송층과 전자 수송층을 사용하면 정공과 전자가 발광층으로 효과적으로 전달될 수 있고 발광층에서 정공과 전자의 밀도가 균형을 이루도록 하여 발광효율을 높이기 위하여 유기 발광 소자를 다층 박막 구조로 제작한다.Stabilizing the interface between the electrode and the organic material, or in the case of the organic material, the hole and electron movement speed is significantly different, so using the appropriate hole transport layer and electron transport layer can be effectively transferred holes and electrons to the light emitting layer and holes in the light emitting layer The organic light emitting device is manufactured in a multi-layered thin film structure in order to balance the density of electrons with the electrons to increase luminous efficiency.
한편, 기존 전자 수송 재료의 대표적인 예로는, Alq3 (tris(8-hydroxyquinoline)aluminum(III)) 및 Bebq (bis(10-hydroxybenzo-[h]quinolinato)beryllium)과 같은 알루미늄 착체 및 베릴륨 착체가 있다. 그러나, 이들 재료의 경우, 청색 발광 소자에 사용할 경우 엑시톤 디퓨젼(exciton diffusion)에 의한 발광 때문에 색순도가 떨어지는 문제점이 있다.Representative examples of existing electron transport materials include aluminum complexes such as Alq3 (tris (8-hydroxyquinoline) aluminum (III)) and Bebq (bis (10-hydroxybenzo- [h] quinolinato) beryllium) and beryllium complexes. However, these materials have a problem of poor color purity due to light emission due to exciton diffusion when used in blue light emitting devices.
또한, 1996년도에 코닥사에서 발표하고 미국특허 제5,645,948호에 개시된 TPBI (하기 구조 참고)는 이미다졸기를 가진 대표적인 전자 수송층용 물질로 알려져 있으며, 벤젠의 1,3,5-치환 위치에 세 개의 N-페닐 벤즈이미다졸기를 함유하고 기능적으로는 전자를 전달하는 능력뿐 아니라 발광층에서 넘어오는 정공을 차단하는 기능도 있으나 실제 소자에 적용하기에는 안정성이 낮은 문제점을 가지고 있다.In addition, TPBI (see structure below), published by Kodak in 1996 and disclosed in US Pat. No. 5,645,948, is known as a representative electron transport layer material having an imidazole group, and is located at the 1,3,5-substituted position of benzene. It contains N-phenyl benzimidazole groups and functionally blocks electrons from the light emitting layer as well as the ability to transfer electrons, but has a problem of low stability for practical application.
종래의 전자 수송 재료에 있어서, 특히 주목할 만한 것은 발표하는 내용 대비 실제로 단순히 구동 전압만을 약간 개선한다거나, 소자 구동 수명의 현저한 저하 등의 문제점들을 보이고 있고, 컬러별 소자 수명의 편차 및 열적 안정성 저하 등의 부작용적 특성을 나타낸다는 것이다. In the conventional electron transporting material, it is particularly noteworthy that compared to what is disclosed, there are problems such as a simple improvement in driving voltage only, a significant reduction in device driving life, and a variation in device life and thermal stability by color. Side effects.
또한, 기존 유기 발광 소자는 형광 발광 재료를 사용하고 있었으나, 점차 인광 발광 재료를 채용하는 경향으로 변화하고 있다. 따라서, 공통 재료인 전자 수송층 재료 역시 인광 재료에 맞는 적절한 전자이동도, 낮은 구동전압 및 정공 저지 특성이 요구된다.
In addition, although the conventional organic light emitting device uses a fluorescent light emitting material, it is gradually changing to a tendency to employ a phosphorescent light emitting material. Therefore, the electron transport layer material, which is a common material, also requires appropriate electron mobility, low driving voltage, and hole blocking property suitable for phosphorescent materials.
따라서 본 발명은 상기 종래 기술의 문제점을 고려하여, 발광효율, 안정성 및 소자 수명을 크게 향상시킬 수 있는 신규한 전자 수송 물질을 제공하는데 목적이 있다.Accordingly, an object of the present invention is to provide a novel electron transport material capable of greatly improving luminous efficiency, stability, and device life, in consideration of the problems of the prior art.
또한, 본 발명은 상기 신규한 전자 수송 물질을 이용하여 발광특성이 뛰어날 뿐만 아니라 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력이 개선된 유기 발광 소자를 제공하는데 다른 목적이 있다.
Another object of the present invention is to provide an organic light emitting device having excellent light emission characteristics by using the novel electron transport material and inducing power efficiency by increasing driving voltage to improve power consumption.
본 발명은 하기 화학식 1로 표시되는 전자 수송 물질 및 이를 포함하는 유기 발광 소자에 관한 것으로서, 본 발명에 따른 전자 수송 물질을 이용하여 발광특성이 뛰어날 뿐만 아니라 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력이 개선된 유기 발광 소자를 제조할 수 있는 장점이 있다.The present invention relates to an electron transporting material represented by the following Chemical Formula 1 and an organic light emitting device including the same, wherein the electron transporting material according to the present invention not only has excellent luminescence properties but also enhances driving voltage to increase power efficiency. Induction has an advantage of manufacturing an organic light emitting device with improved power consumption.
[화학식 1][Formula 1]
상기 화학식 1에서,In Formula 1,
Ar은 (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이고;Ar is (C6-C30) arylene or (C3-C30) heteroarylene;
L1 및 L2는 서로 독립적으로 단일결합, (C1-C30)알킬렌, (C6-C30)아릴렌, (C3-C30)시클로알킬렌 또는 (C3-C30)헤테로아릴렌이고;L 1 and L 2 are independently of each other a single bond, (C1-C30) alkylene, (C6-C30) arylene, (C3-C30) cycloalkylene or (C3-C30) heteroarylene;
R1 및 R2는 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, -CR'=CR''R''', (C6-C30)아릴 또는 (C3-C30)헤테로아릴이며, 단 R1과 R2 중 반드시 하나 이상은 , 또는 이고;R 1 and R 2 independently of one another are hydrogen, (C1-C30) alkyl, (C3-C30) cycloalkyl, -CR '= CR''R''', (C6-C30) aryl or (C3-C30) Heteroaryl, provided that at least one of R 1 and R 2 is , or ego;
L3 및 L4는 서로 독립적으로 단일결합 또는 (C6-C30)아릴렌이고;L 3 and L 4 are independently of each other a single bond or (C6-C30) arylene;
R', R'', R''', R3 내지 R5는 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;R ', R'',R''', R 3 to R 5 independently of one another are hydrogen, (C1-C30) alkyl, (C3-C30) cycloalkyl, (C6-C30) aryl or (C3-C30) Heteroaryl;
X는 O 또는 S이고;X is O or S;
상기 Ar의 아릴렌 및 헤테로아릴렌, L1 및 L2의 알킬렌, 아릴렌, 시클로알킬렌 및 헤테로아릴렌, 및 R1 내지 R5의 알킬, 시클로알킬, 아릴 및 헤테로아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있고;The arylene and heteroarylene of Ar, alkylene, arylene, cycloalkylene and heteroarylene of L 1 and L 2 , and alkyl, cycloalkyl, aryl and heteroaryl of R 1 to R 5 are (C1- C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C3-C30) cycloalkyl, (C1-C30) alkoxy, (C6-C30) aryloxy, (C6-C30) aryl, (C1- C30) alkyl (C6-C30) aryl, (C6-C30) ar (C1-C30) alkyl, (C3-C30) heteroaryl, (C1-C30) alkyl substituted (C3-C30) heteroaryl, (C6 (C3-C30) heteroaryl, mono or di (C1-C30) alkylamino, mono or di (C6-C30) arylamino, tri (C1-C30) alkylsilyl, di (C1-) C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, nitro and hydroxy may be further substituted with one or more selected from the group consisting of;
상기 헤테로아릴렌 및 헤테로아릴은 B, N, O, S, P(=O), Si 및 P로부터 선택된 하나 이상의 헤테로원자를 포함한다.
The heteroarylene and heteroaryl include one or more heteroatoms selected from B, N, O, S, P (= 0), Si and P.
본 발명에 기재된 「알킬」, 「알콕시」 및 그 외 「알킬」부분을 포함하는 치환체는 직쇄 또는 분쇄 형태를 모두 포함하고, 「시클로알킬」은 단일 고리계 뿐만 아니라 치환 또는 비치환된 아다만틸 또는 치환 또는 비치환된 (C7-C30)바이시클로알킬과 같은 여러 고리계 탄화수소도 포함한다. 본 발명에 기재된 「아릴」은 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 각 고리에 적절하게는 4 내지 7개, 바람직하게는 5 또는 6개의 고리원자를 포함하는 단일 또는 융합고리계를 포함하며, 다수개의 아릴이 단일결합으로 연결되어 있는 형태까지 포함한다. 구체적인 예로서 페닐, 나프틸, 비페닐, 터페닐, 안트릴, 인데닐(indenyl), 플루오레닐, 페난트릴, 트리페닐레닐, 피렌일, 페릴렌일, 크라이세닐, 나프타세닐, 플루오란텐일 등이 있다. 본 발명에 기재된 「헤테로아릴」은 방향족 고리 골격 원자로서 B, N, O, S, P(=O), Si 및 P로부터 선택되는 1 내지 4개의 헤테로원자를 포함하고 나머지 방향족 고리 골격 원자가 탄소인 아릴 그룹을 의미하는 것으로, 5 내지 6원 단환 헤테로아릴, 및 하나 이상의 벤젠 환과 축합된 다환식 헤테로아릴이며, 부분적으로 포화될 수도 있다. 또한, 본 발명에서의 헤테로아릴은 하나 이상의 헤테로아릴이 단일결합으로 연결된 형태도 포함한다. 상기 헤테로아릴기는 고리내 헤테로원자가 산화되거나 사원화되어, 예를 들어 N-옥사이드 또는 4차 염을 형성하는 2가 아릴 그룹을 포함한다. 구체적인 예로서 퓨릴, 티오펜일, 피롤릴, 이미다졸릴, 피라졸릴, 티아졸릴, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아진일, 테트라진일, 트리아졸릴, 테트라졸릴, 퓨라잔일, 피리딜, 피라진일, 피리미딘일, 피리다진일 등의 단환 헤테로아릴, 벤조퓨란일, 벤조티오펜일, 이소벤조퓨란일, 벤조이미다졸릴, 벤조티아졸릴, 벤조이소티아졸릴, 벤조이속사졸릴, 벤조옥사졸릴, 이소인돌릴, 인돌릴, 인다졸릴, 벤조티아디아졸릴, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 퀴녹살리닐, 카바졸릴, 페난트리딘일, 벤조디옥솔릴, 다이벤조퓨란닐, 다이벤조싸이오페닐 등의 다환식 헤테로아릴 및 이들의 상응하는 N-옥사이드(예를 들어, 피리딜 N-옥사이드, 퀴놀릴 N-옥사이드), 이들의 4차 염 등을 들수 있다.Substituents including the "alkyl", "alkoxy" and other "alkyl" moieties described herein include all linear or pulverized forms, and "cycloalkyl" is not only a monocyclic system but also substituted or unsubstituted adamantyl Or several ring-based hydrocarbons such as substituted or unsubstituted (C7-C30) bicycloalkyl. "Aryl" described in the present invention is an organic radical derived from an aromatic hydrocarbon by one hydrogen removal, and a single or fused ring containing 4 to 7, preferably 5 or 6 ring atoms in each ring as appropriate. It includes a system, including a form in which a plurality of aryl is connected by a single bond. Specific examples include phenyl, naphthyl, biphenyl, terphenyl, anthryl, indenyl, fluorenyl, phenanthryl, triphenylenyl, pyrenyl, peryleneyl, chrysenyl, naphthacenyl, fluoranthenyl and the like. There is this. "Heteroaryl" described in the present invention contains 1 to 4 heteroatoms selected from B, N, O, S, P (= O), Si and P as aromatic ring skeleton atoms, and the remaining aromatic ring skeleton atoms are carbon. Means an aryl group, 5-6 membered monocyclic heteroaryl, and polycyclic heteroaryl condensed with one or more benzene rings, which may be partially saturated. In addition, heteroaryl in the present invention also includes a form in which one or more heteroaryl is connected by a single bond. Such heteroaryl groups include divalent aryl groups in which heteroatoms in the ring are oxidized or quaternized to form, for example, N-oxides or quaternary salts. Specific examples include furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, triazinyl, tetrazinyl, triazolyl, Monocyclic heteroaryl such as tetrazolyl, furazanyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, benzofuranyl, benzothiophenyl, isobenzofuranyl, benzoimidazolyl, benzothiazolyl, benzoiso Thiazolyl, benzoisoxazolyl, benzoxazolyl, isoindolyl, indolyl, indazolyl, benzothiadiazolyl, quinolyl, isoquinolyl, cinnaolinyl, quinazolinyl, quinoxalinyl, carbazolyl, phenantri Polycyclic heteroaryls such as dinyl, benzodioxyl, dibenzofuranyl, dibenzothiophenyl and their corresponding N-oxides (e.g. pyridyl N-oxides, quinolyl N-oxides), Quaternary salts;
또한, 본 발명에 기재되어 있는 ‘(C1-C30)알킬’기는 바람직하게는 (C1-C20)알킬이고, 더 바람직하게는 (C1-C10)알킬이며, ‘(C6-C30)아릴’기는 바람직하게는 (C6-C20)아릴이다. ‘(C3-C30)헤테로아릴’기는 바람직하게는 (C3-C20)헤테로아릴이다. ‘(C3-C30)시클로알킬’기는 바람직하게는 (C3-C20)시클로알킬이고, 더 바람직하게는 (C3-C7)시클로알킬이다.Further, the '(C1-C30) alkyl' group described in the present invention is preferably (C1-C20) alkyl, more preferably (C1-C10) alkyl, and the '(C6-C30) aryl' group is preferred. Preferably (C6-C20) aryl. The '(C3-C30) heteroaryl' group is preferably (C3-C20) heteroaryl. The '(C3-C30) cycloalkyl' group is preferably (C3-C20) cycloalkyl, more preferably (C3-C7) cycloalkyl.
상기 화학식 1의 전자 수송 물질에서, Ar은 하기 구조에서 선택되는 것이 바람직하다.In the electron transporting material of Chemical Formula 1, Ar is preferably selected from the following structures.
[상기 R11 내지 R21은 서로 독립적으로 수소, (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 또는 하이드록시이고; a 내지 d는 서로 독립적으로 1 내지 4의 정수이고; e는 1 또는 2의 정수이다.]
[The above R 11 to R 21 are independently of each other hydrogen, (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C3-C30) cycloalkyl, (C1-C30) alkoxy, (C6 -C30) aryloxy, (C6-C30) aryl, (C1-C30) alkyl (C6-C30) aryl, (C6-C30) ar (C1-C30) alkyl, (C3-C30) heteroaryl, (C1- (C3-C30) heteroaryl substituted with alkyl, (C3-C30) heteroaryl substituted with (C3-C30) aryl, mono or di (C1-C30) alkylamino, mono or di (C6-C30) Arylamino, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, nitro or hydroxy; a to d are each independently an integer of 1 to 4; e is an integer of 1 or 2.]
보다 구체적으로, 본 발명의 전자 수송 물질은 하기 화학식 2 내지 8로 표시될 수 있다.More specifically, the electron transporting material of the present invention may be represented by the following Chemical Formulas 2 to 8.
[화학식 2][Formula 2]
[화학식 3](3)
[화학식 4][Formula 4]
[화학식 5][Chemical Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
[상기 화학식 2 내지 8에서, L1 및 L2는 서로 독립적으로 단일결합, (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이고, 상기 L1 및 L2의 아릴렌 및 헤테로아릴렌은 (C1-C30)알킬 또는 (C6-C30)아릴로 더 치환될 수 있고; R1은 수소, (C1-C30)알킬, -CR'=CR''R''', (C6-C30)아릴, (C3-C30)헤테로아릴 또는 이고, 상기 R1의 알킬, 아릴 및 헤테로아릴은 (C1-C30)알킬 또는 (C6-C30)아릴로 더 치환될 수 있고; R11 내지 R20은 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴 또는 (C3-C30)헤테로아릴이고, 단, R11과 R12가 동시에 수소인 경우는 제외되고; R2는 , 또는 이고; L3 및 L4는 서로 독립적으로 단일결합 또는 (C6-C30)아릴렌이고; R', R'', R''', R3 내지 R5는 서로 독립적으로 수소, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고; X는 O 또는 S이고; a 내지 d는 서로 독립적으로 1 내지 4의 정수이다.]
[
본 발명에 따른 전자 수송 물질은 하기의 화합물들로 예시될 수 있으나, 이에 한정되는 것은 아니다. The electron transporting material according to the present invention may be exemplified by the following compounds, but is not limited thereto.
본 발명에 따른 전자 수송 물질은 하기 반응식에 나타난 바와 같이 제조될 수 있으나, 이에 한정되는 것은 아니며, 공지의 유기반응을 통하여 제조될 수도 있다.The electron transporting material according to the present invention may be prepared as shown in the following scheme, but is not limited thereto, and may be prepared through known organic reactions.
[반응식 1][Reaction Scheme 1]
[상기 반응식 1에서, L1, L2, Ar, R1 및 R2는 상기 화학식 1에서의 정의와 동일하고, Hal는 할로겐이다.][In Reaction Scheme 1, L 1 , L 2 , Ar, R 1 and R 2 are the same as defined in Formula 1, and Hal is halogen.]
또한, 본 발명은 유기 발광 소자를 제공하며, 본 발명에 따른 유기 발광 소자는 제1전극; 제2전극; 및 상기 제1전극 및 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어져 있으며, 상기 유기물층은 상기 화학식 1의 전자 수송 물질이 포함된 전자 수송층을 포함한다. 본 발명에 따른 상기 화학식 1의 전자 수송 물질을 전자 수송층에 사용하는 경우 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력을 개선시킨다.In addition, the present invention provides an organic light emitting device, the organic light emitting device according to the present invention comprises: a first electrode; A second electrode; And at least one organic material layer interposed between the first electrode and the second electrode, wherein the organic material layer includes an electron transport layer including the electron transport material of Chemical Formula 1. When the electron transporting material of Chemical Formula 1 according to the present invention is used in the electron transporting layer, the driving voltage is enhanced to induce an increase in power efficiency, thereby improving power consumption.
또한, 상기 유기물층은 상기 화학식 1의 전자 수송 물질이 포함된 전자 수송층 하나 이상과 형광호스트-형광도판트 또는 인광호스트-인광도판트로 이루어진 발광층 하나 이상을 포함하는 것을 특징으로 하며, 본 발명의 유기 발광 소자에 적용되는 형광호스트, 형광도판트, 인광호스트 또는 인광도판트는 특별히 제한되지는 않는다.
In addition, the organic material layer is characterized in that it comprises at least one electron transport layer containing the electron transport material of Formula 1 and at least one light emitting layer consisting of a fluorescent host-fluorescent dopant or a phosphorescent host-phosphorescent dopant, the organic light emitting of the present invention The fluorescent host, fluorescent dopant, phosphorescent host or phosphorescent dopant applied to the device is not particularly limited.
본 발명에 따른 전자 수송 물질은 발광특성이 뛰어날 뿐만 아니라 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력이 개선된 유기 발광 소자를 제작할 수 있는 장점이 있다.
The electron transporting material according to the present invention has an advantage in that an organic light emitting device having excellent light emission characteristics and inducing power efficiency by inducing a driving voltage to increase power consumption can be manufactured.
도 1 - 실시예 14 내지 24 및 비교예 2에서 제작된 유기 발광 소자의 효율(cd/A)-휘도(cd/㎡) 그래프1-Graph of efficiency (cd / A) -luminance (cd / m 2) of organic light emitting diodes manufactured in Examples 14 to 24 and Comparative Example 2
이하에서, 본 발명의 상세한 이해를 위하여 본 발명의 대표 화합물을 들어 본 발명에 따른 전자 수송 화합물, 이의 제조방법 및 소자의 발광특성을 설명하며, 하기의 실시예는 본 발명의 예시 목적을 위한 것으로서 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.Hereinafter, the electron transport compound according to the present invention, a method for producing the same and a light emitting property of the device for the detailed understanding of the present invention for the detailed understanding of the present invention, the following examples are for the purpose of illustrating the present invention as It is not intended to limit the scope of protection of the present invention.
[제조예 1] 화합물 1의 제조Preparation Example 1 Preparation of Compound 1
화합물 compound 1-11-1 의 제조Manufacturing
메틸렌클로라이드 (MC, 31mL)와 3-브로모벤조일클로라이드 (25g, 0.1139mol)을 혼합하고 -10℃에서 교반하였다. 3-브로모벤조일클로라이드가 완전히 용해된 후 피리딘(106mL)와 2-클로로피리딘-3-아민 (13.2g)의 혼합용액을 천천히 적가하고 교반하였다. 2시간 30동안 후 물 (1250mL)를 가하고 생성된 고체 화합물을 여과하고, 메탄올로 씻어주었다. 건조 후 흰색의 고체 화합물 1-1 (28.0g, 수율 87%)을 얻었다.Methylene chloride (MC, 31 mL) and 3-bromobenzoyl chloride (25 g, 0.1139 mol) were mixed and stirred at -10 ° C. After 3-bromobenzoyl chloride was completely dissolved, a mixed solution of pyridine (106 mL) and 2-chloropyridin-3-amine (13.2 g) was slowly added dropwise and stirred. After 2 hours and 30 hours, water (1250 mL) was added, and the resulting solid compound was filtered and washed with methanol. After drying, a white solid compound 1-1 (28.0 g, yield 87%) was obtained.
화합물compound 1-2 1-2 의 제조Manufacturing
1,3-디메틸-3,4,5,6-테트라하이드로-2(1H)-피리미디논 (DMPU, 110mL)와 화합물 1-1 (27g, 0.0866 mol)과 로슨시약 (35.1g)을 혼합하고 환류교반하였다. 2시간 30분 후 에틸아세테이트(EA)로 추출하고 농축하여 연한 노란색의 고체 화합물 1-2 (20g, 수율80%)을 얻었다.Mix 1,3-dimethyl-3,4,5,6-tetrahydro-2 (1H) -pyrimidinone (DMPU, 110 mL), compound 1-1 (27 g, 0.0866 mol) and Lawson reagent (35.1 g) And reflux was stirred. After 2 hours 30 minutes, the mixture was extracted with ethyl acetate (EA) and concentrated to give a pale yellow solid compound 1-2 (20 g, yield 80%).
1H NMR (CDCl3) δ [ppm]: 8.61(dd, 1H), 8.33(d, 1H), 8.30(t, 1H), 8.02(m, 1H), 7.67(m, 1H), 7.48(q, 1H), 7.41(t, 1H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.61 (dd, 1H), 8.33 (d, 1H), 8.30 (t, 1H), 8.02 (m, 1H), 7.67 (m, 1H), 7.48 (q , 1H), 7.41 (t, 1H)
화합물 compound 1One 의 제조Manufacturing
THF/물(490mL/246mL)의 혼합용매에 4,4,5,5-테트라메틸-2-(10-(나프탈렌-1-일)안트라센-9-일)-1,3,2-다이옥사보레인 (9.8g, 0.0227mol), 화합물 1-2 (7.3g, 0.025mol), Pd(PPh3)4 (2.7g, 0.00233 mol)과 K2CO3 (6.3g, 0.0456 mol)을 혼합하고 환류교반시켰다. 12시간 후 메틸렌 클로라이드(MC)로 추출하고 농축하였다. 농축된 잔사를 에틸아세테이트(EA)에 용해하고 메탄올을 적가하여 재결정한 다음, 생성물을 여과하여 노란색의 고체 화합물 1 (5g, 수율43%)을 얻었다.4,4,5,5-tetramethyl-2- (10- (naphthalen-1-yl) anthracene-9-yl) -1,3,2-dioxabo in a mixed solvent of THF / water (490 mL / 246 mL) Lane (9.8 g, 0.0227 mol), compound 1-2 (7.3 g, 0.025 mol), Pd (PPh 3 ) 4 (2.7 g, 0.00233 mol) and K 2 CO 3 (6.3 g, 0.0456 mol) are mixed and refluxed Stirred. After 12 h extracted with methylene chloride (MC) and concentrated. The concentrated residue was dissolved in ethyl acetate (EA) and recrystallized by dropwise adding methanol. The product was filtered to give a yellow solid Compound 1 (5 g, yield 43%).
1H NMR (CDCl3) δ [ppm]: 8.61(m, 1H), 8.34(m, 3H), 8.11(d, 1H), 8.06(d, 1H), 7.80(m, 5H), 7.63(m, 1H), 7.51(m, 4H), 7.38(t, 2H), 7.28(m, 3H), 7.20(t, 1H); MALDI-TOF MS: m/z 514.34, cal. 514.64
1 H NMR (CDCl 3 ) δ [ppm]: 8.61 (m, 1H), 8.34 (m, 3H), 8.11 (d, 1H), 8.06 (d, 1H), 7.80 (m, 5H), 7.63 (m , 1H), 7.51 (m, 4H), 7.38 (t, 2H), 7.28 (m, 3H), 7.20 (t, 1H); MALDI-TOF MS: m / z 514.34, cal. 514.64
[제조예 2] 화합물 2의 제조Preparation Example 2 Preparation of
THF/물(425mL:213mL)의 혼합용매에 4,4,5,5-테트라메틸-2-(10-(나프탈렌-3-일)안트라센-9-일)-1,3,2-다이옥사보레인 (8.5g, 0.0197mol), 화합물 1-2 (6.14g, 0.021mol), Pd(PPh3)4 (2.3g, 0.00198 mol)과 K2CO3 (5.44g, 0.0394 mol)을 혼합하고 환류교반시켰다. 12시간 후 메틸렌 클로라이드(MC)로 추출하고 농축하였다. 농축된 잔사를 에틸아세테이트(EA)에 용해하고 메탄올을 적가하여 재결정한 다음, 생성물을 여과하여 노란색의 고체 화합물 2 (5.01g, 수율50%)을 얻었다.4,4,5,5-tetramethyl-2- (10- (naphthalen-3-yl) anthracene-9-yl) -1,3,2-dioxabo in a mixed solvent of THF / water (425 mL: 213 mL) Lanes (8.5 g, 0.0197 mol), compounds 1-2 (6.14 g, 0.021 mol), Pd (PPh 3 ) 4 (2.3 g, 0.00198 mol) and K 2 CO 3 (5.44 g, 0.0394 mol) was mixed and stirred at reflux. After 12 h extracted with methylene chloride (MC) and concentrated. The concentrated residue was dissolved in ethyl acetate (EA) and recrystallized by dropwise adding methanol. The product was filtered to give a yellow solid Compound 2 (5.01 g, yield 50%).
1H NMR (DMSO-d6) δ [ppm]: 8.65(dd, 1H), 8.45(m, 1H), 8.40(m, 1H), 8.23(m, 2H), 8.15(m, 1H), 8.08(m, 2H), 7.95(t, 1H), 7.79(m, 1H), 7.66(m, 8H), 7.47(m, 4H); MALDI-TOF MS: m/z 514.14, cal. 514.64
1 H NMR (DMSO-d 6 ) δ [ppm]: 8.65 (dd, 1H), 8.45 (m, 1H), 8.40 (m, 1H), 8.23 (m, 2H), 8.15 (m, 1H), 8.08 (m, 2H), 7.95 (t, 1H), 7.79 (m, 1H), 7.66 (m, 8H), 7.47 (m, 4H); MALDI-TOF MS: m / z 514.14, cal. 514.64
[제조예 3] 화합물 3의 제조Preparation Example 3 Preparation of
화합물compound 3-1 3-1 의 제조Manufacturing
CuBr2 (60.03g, 0.27mol), t-부틸나이트레이트 (39.96mL, 0.34mol)과 아세토나이트릴 (825mL)을 혼합하고 65℃로 승온하였다. 상기 반응물에 2-아미노안트라퀴논 (50g, 0.22mol)를 넣고 65℃에서 5시간 동안 교반하였다. 교반이 완료된 후 실온으로 냉각하고 20wt% 염산수용액 (2856mL)를 가하고 1시간 동안 교반한 후 갑압여과 하였다. 얻어진 고체를 메틸렌클로라이드(MC)로 유기층을 추출한 후 감압 농축하였다. 감압농축하여 얻어진 고체를 MC/Hexane(부피비:4/1)의 혼합용매로 용해시킨 다음, 실리카겔 여과하고 여액을 감압 농축하고 아세톤으로 씻어주어 화합물 3-1 (수율 45%)을 얻었다.CuBr 2 (60.03 g, 0.27 mol), t-butyl nitrate (39.96 mL, 0.34 mol) and acetonitrile (825 mL) were mixed and heated to 65 ° C. 2-aminoanthraquinone (50 g, 0.22 mol) was added to the reaction and stirred at 65 ° C. for 5 hours. After stirring was completed, the mixture was cooled to room temperature, 20 wt% aqueous hydrochloric acid solution (2856 mL) was added thereto, stirred for 1 hour, and filtered under pressure. The obtained solid was extracted with methylene chloride (MC), and then concentrated under reduced pressure. The solid obtained by concentrating under reduced pressure was dissolved in a mixed solvent of MC / Hexane (volume ratio: 4/1), filtered through silica gel, and the filtrate was concentrated under reduced pressure and washed with acetone to obtain compound 3-1 (yield 45%).
화합물compound 3-2 3-2 의 제조Manufacturing
질소 분위기 하에서 정제된 THF (453mL)에 2-브로모나프탈렌 (49.83g, 0.24mol)을 투입하고 -78℃에서 30분간 교반하였다. 상기 반응액에 t-부틸리튬 (212.03mL, 2.16mol)을 천천히 투입하고 1시간동안 교반한 후 화합물 3-1 (28.78g, 0.10mol)을 신속히 가하고 24시간동안 교반하였다. 교반이 완료되면 포화된 염화암모늄 수용액을 투입하고, 메틸렌클로라이드(MC)로 유기층을 추출한 후 실리카겔 여과하고 얻어진 여액을 감압 농축하였다. 생성된 고체를 에틸에테르로 녹인 후 석유에테르로 재결정시켜 화합물 3-2 (수율 91%)를 얻었다.2-bromonaphthalene (49.83 g, 0.24 mol) was added to THF (453 mL) purified under a nitrogen atmosphere, and stirred at -78 ° C for 30 minutes. T-butyllithium (212.03mL, 2.16mol) was slowly added to the reaction solution, stirred for 1 hour, and then Compound 3-1 (28.78g, 0.10mol) was added rapidly and stirred for 24 hours. When stirring was completed, a saturated aqueous ammonium chloride solution was added, the organic layer was extracted with methylene chloride (MC), filtered through silica gel, and the filtrate was concentrated under reduced pressure. The resulting solid was dissolved in ethyl ether and recrystallized from petroleum ether to give compound 3-2 (yield 91%).
화합물compound 3-3 3-3 의 제조Manufacturing
화합물 3-2 (50.00g, 0.09mol)에 아세트산 (650mL)를 투입한 후 KI (152.74g, 0.92mol)와 NaH2PO2ㆍH2O (165.95g, 1.89mol)를 투입하고 환류교반하였다. 24시간 후 실온으로 냉각하고, 물 (650mL)를 가하고 1시간 동안 교반하였다. 교반이 완료되면 감압여과하고 메탄올로 씻어주어 화합물 3-3 (수율 61%)를 얻었다.Acetic acid (650 mL) was added to Compound 3-2 (50.00 g, 0.09 mol), and KI (152.74 g, 0.92 mol) and NaH 2 PO 2 ㆍ H 2 O (165.95 g, 1.89 mol) were added and refluxed under stirring. . After 24 hours, cooled to room temperature, water (650 mL) was added and stirred for 1 hour. After stirring was complete, the mixture was filtered under reduced pressure and washed with methanol to obtain compound 3-3 (yield 61%).
화합물compound 3-4 3-4 의 제조Manufacturing
화합물 3-3 (25.00g, 0.05mol), KOAc (14.45g, 0.15mol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (16.20g, 0.06mol), PdCl2(dppf) (2.40g, 0.003mol)과 디옥산 (250mL)를 혼합하고 환류교반하였다. 24시간 후 MC로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 3-4 (수율 72%)를 얻었다.Compound 3-3 (25.00g, 0.05mol), KOAc (14.45g, 0.15mol), Bis (pinacolato) diboron (16.20g, 0.06mol), PdCl 2 (dppf) ( 2.40 g, 0.003 mol) and dioxane (250 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with acetone to obtain compound 3-4 (yield 72%).
화합물
화합물 3-4 (17.00g, 0.03mol), 화합물 1-2 (11.12g, 0.04mol), Pd2(dba)3 (1.40g, 0.0015mol), PPh3 (0.88g, 0.003mol), K2CO3 (8.44g, 0.06mol), THF (51mL)와 물 (17mL)를 혼합하고 환류교반하였다. 24시간 후 MC로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 3 (수율 57%)를 얻었다.Compound 3-4 (17.00g, 0.03mol), Compound 1-2 (11.12g, 0.04mol), Pd 2 (dba) 3 (1.40g, 0.0015mol), PPh 3 (0.88g, 0.003mol), K 2 CO 3 (8.44 g, 0.06 mol), THF (51 mL) and water (17 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with acetone to obtain compound 3 (yield 57%).
1H NMR (CDCl3) δ [ppm]: 8.59(dd, 1H), 8.33(d, 1H), 8.28(m, 1H), 8.17(q, 2H), 8.05(m, 7H), 7.90(m, 2H), 7.81(m, 1H), 7.72(m, 2H), 7.65(m, 4H), 7.53(m, 2H), 7.48(m, 1H), 7.37(m, 2H), 7.26(m, 2H); MALDI-TOF MS: m/z 639.86, cal. 640.20
1 H NMR (CDCl 3 ) δ [ppm]: 8.59 (dd, 1H), 8.33 (d, 1H), 8.28 (m, 1H), 8.17 (q, 2H), 8.05 (m, 7H), 7.90 (m) , 2H), 7.81 (m, 1H), 7.72 (m, 2H), 7.65 (m, 4H), 7.53 (m, 2H), 7.48 (m, 1H), 7.37 (m, 2H), 7.26 (m, 2H); MALDI-TOF MS: m / z 639.86, cal. 640.20
[제조예 4] 화합물 4의 제조Preparation Example 4 Preparation of Compound 4
화합물 compound 4-14-1 의 제조Manufacturing
2-아미노-5-브로모피리딘 (30.00g, 0.17mol)에 IPA (Isopropyl alcohol, 90mL)를 가한 후 교반하였다. 상기 반응액에 디메틸포름아마이드-디메틸아세탈 (DMF-DMA, 29.85mL, 0.23mol)를 투입하고 환류교반하였다. 3시간 후 50℃로 냉각하고, 동온도에서 NH2OHㆍHCl (15.67g, 0.23mol)를 투입하고 24시간 동안 교반하였다. 교반이 완료되면 IPA로 세정하여 화합물 4-1 (수율 62%)를 얻었다.IPA (Isopropyl alcohol, 90 mL) was added to 2-amino-5-bromopyridine (30.00 g, 0.17 mol), followed by stirring. Dimethylformamide-dimethylacetal (DMF-DMA, 29.85mL, 0.23mol) was added to the reaction solution, and the mixture was stirred under reflux. After 3 hours, the mixture was cooled to 50 ° C, NH 2 OH.HCl (15.67 g, 0.23 mol) was added thereto, and stirred for 24 hours. After stirring was complete, the mixture was washed with IPA to give compound 4-1 (yield 62%).
1H NMR (DMSO-d6) δ [ppm]: 10.20(s, 1H), 9.57(d, 1H), 8.23(d, 1H), 8.81(dd, 1H), 7.78(d, 1H), 7.04(d, 1H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 10.20 (s, 1H), 9.57 (d, 1H), 8.23 (d, 1H), 8.81 (dd, 1H), 7.78 (d, 1H), 7.04 (d, 1H)
화합물 compound 4-24-2 의 제조Manufacturing
화합물 4-1 (23.00g, 0.11mol)에 THF (230mL)를 투입한 후 0℃에서 트리플루오르아세트산 무수물 (22.22mL, 0.16mol)를 투입하고 실온에서 24시간 동안 교반하였다. 상기 반응액에 포화된 중탄산나트륨 수용액을 가하고 1시간 동안 교반하였다. 교반이 완료되면 MC로 유기층을 추출하고 감압 농축한 다음, 에틸에테르로 세척하여 화합물 4-2 (수율 46%)를 얻었다. THF (230 mL) was added to Compound 4-1 (23.00 g, 0.11 mol), trifluoroacetic anhydride (22.22 mL, 0.16 mol) was added at 0 ° C., and stirred at room temperature for 24 hours. Saturated aqueous sodium bicarbonate solution was added to the reaction solution and stirred for 1 hour. After stirring was complete, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with ethyl ether to obtain compound 4-2 (yield 46%).
1H NMR (DMSO-d6) δ [ppm]: 9.42(s, 1H), 9.54(s, 1H), 7.84(m, 2H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 9.42 (s, 1 H), 9.54 (s, 1 H), 7.84 (m, 2 H)
화합물 compound 44 의 제조Manufacturing
화합물 3-4 (30.00g, 0.05mol), 화합물 4-2 (12.81g, 0.06mol), Pd(pph3)4 (1.87g, 0.0016mol), K2CO3 (14.89g, 0.11mol), THF (90mL)와 물 (30mL)를 혼합하고 환류교반하였다. 24시간 후 EA로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 4 (수율 52%)를 얻었다.Compound 3-4 (30.00 g, 0.05 mol), compound 4-2 (12.81 g, 0.06 mol), Pd (pph 3 ) 4 (1.87 g, 0.0016 mol), K 2 CO 3 (14.89 g, 0.11 mol), THF (90 mL) and water (30 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with EA, concentrated under reduced pressure and washed with acetone to obtain compound 4 (yield 52%).
1H NMR (DMSO-d6) δ [ppm]: 8.27(d, 1H), 8.14(d, 2H), 8.05(m, 4H), 7.96(m, 2H), 7.84(m, 2H), 7.78(m, 2H), 7.67(m, 6H), 7.57(m, 3H), 7.34(q, 2H), 6.49(d, 1H); MALDI-TOF MS: m/z 547.82, cal. 547.65
1 H NMR (DMSO-d 6 ) δ [ppm]: 8.27 (d, 1H), 8.14 (d, 2H), 8.05 (m, 4H), 7.96 (m, 2H), 7.84 (m, 2H), 7.78 (m, 2H), 7.67 (m, 6H), 7.57 (m, 3H), 7.34 (q, 2H), 6.49 (d, 1H); MALDI-TOF MS: m / z 547.82, cal. 547.65
[제조예 5] 화합물 5의 제조Preparation Example 5 Preparation of Compound 5
화합물 compound 5-15-1 의 제조Manufacturing
질소 분위기 하에서 정제된 THF (500mL)에 9-브로모페난트렌 (40g, 155.6mmol)투입하였다. 상기 반응물의 온도를 -78℃로 유지하면서 2.5M 부틸리튬 (68.4 mL, 171.1mmol)을 천천히 투입하고, 1시간동안 교반한 후 B(Oi-Pr)3 (42.9mL, 186.7mmol)를 첨가하였다. 온도를 상온으로 올리고 2N 염산 수용액 (250mL)를 가하고 3시간 동안 교반하였다. 교반이 완료되면, 포화 NaCl수용액과 에틸아세테이트(EA)로 유기층을 추출하고 MgSO4로 건조한 후 여과하고, 감압 농축하였다. 감압 농축하여 얻어진 고체를 핵산에 현탁 교반하고, 여과한 후, 핵산으로 세척하여 화합물 5-1 (28g, 수율81%)을 얻었다.9-bromophenanthrene (40 g, 155.6 mmol) was added to THF (500 mL) purified under a nitrogen atmosphere. 2.5M butyllithium (68.4 mL, 171.1 mmol) was slowly added while maintaining the temperature of the reaction at -78 ° C, stirred for 1 hour, and then B (Oi-Pr) 3 (42.9 mL, 186.7 mmol) was added. . The temperature was raised to room temperature, 2N hydrochloric acid aqueous solution (250 mL) was added, and the mixture was stirred for 3 hours. After stirring was complete, the organic layer was extracted with saturated aqueous NaCl solution and ethyl acetate (EA), dried over MgSO 4 , filtered, and concentrated under reduced pressure. The solid obtained by concentrating under reduced pressure was suspended and stirred in a nucleic acid, filtered and washed with a nucleic acid to obtain compound 5-1 (28 g, yield 81%).
1H NMR (DMSO-d6) δ [ppm]: 8.82 (t, 2H), 8.50 (s, 2H), 8.40-8.38 (d, 1H), 8.04 (s, 1H), 7.99-7.97 (d, 1H), 7.71-7.66 (m, 4H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 8.82 (t, 2H), 8.50 (s, 2H), 8.40-8.38 (d, 1H), 8.04 (s, 1H), 7.99-7.97 (d, 1H), 7.71-7.66 (m, 4H)
화합물compound 5-2 5-2 의 제조Manufacturing
2,4-디클로로피리미딘 (15.00g, 0.10mol), 화합물 5-1 (24.59g, 0.11mol), Pd(PPh3)4 (3.49g, 0.003mol), K2CO3 (27.81g, 0.2mol), THF (45mL)와 물 (15mL)를 혼합하고 환류교반하였다. 24시간 후 MC로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 5-2 (수율 76%)를 얻었다.2,4-dichloropyrimidine (15.00g, 0.10mol), compound 5-1 (24.59g, 0.11mol), Pd (PPh 3 ) 4 (3.49g, 0.003mol), K 2 CO 3 (27.81 g, 0.2 mol), THF (45 mL) and water (15 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with acetone to obtain compound 5-2 (yield 76%).
화합물compound 5-3 5-3 의 제조Manufacturing
화합물 1-2 (27.47g, 103mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (27.47g, 108mmol), 1,4-다이옥산 (450mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물(1,1'-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex) (1.68g, 2.1mmol)과 CH3CO2K (20.22g, 206.1mmol)을 혼합하고 12시간동안 환류교반한 다음, 상온으로 냉각하였다. 상기 반응물에 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축한 후 얻어진 고체를 핵산에 현탁 교반하고, 여과한 후, 핵산으로 세척하여 화합물 5-3 (41.8g, 수율 89 %)를 얻었다.Compound 1-2 (27.47g, 103mmol), Bis (pinacolato) diboron (27.47g, 108mmol), 1,4-dioxane (450mL), 1,1'-bis (di Phenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1,1'-Bis (diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex) (1.68 g, 2.1 mmol) and CH 3 CO 2 K (20.22 g, 206.1 mmol) were mixed and stirred under reflux for 12 hours, and then cooled to room temperature. Saturated NaCl solution and ethyl acetate (EA) were added to the reaction mixture, the organic layer was extracted, dried over MgSO 4 , and treated with activated carbon and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was suspended and stirred in nucleic acid, filtered and washed with nucleic acid to obtain compound 5-3 (41.8 g, 89% yield).
1H NMR (CDCl3) δ [ppm]: 8.60-8.58 (d, 1H), 8.50 (s, 1H), 8.32-8.30 (d, 1H), 8.25-8.22 (d, 1H), 7.99-7.97 (d, 1H), 7.55 (t, 1H), 7.48-7.44 (q, 1H), 1.40 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.60-8.58 (d, 1H), 8.50 (s, 1H), 8.32-8.30 (d, 1H), 8.25-8.22 (d, 1H), 7.99-7.97 ( d, 1H), 7.55 (t, 1H), 7.48-7.44 (q, 1H), 1.40 (s, 12H)
화합물compound 5 5 의 제조Manufacturing
화합물 5-2 (22.00g, 0.08mol), 화합물 5-3 (33.65g, 0.10mol), Pd(PPh3)4 (2.65g, 0.002mol), K2CO3 (21.14g, 0.15mol), THF (66mL)와 물 (22mL)를 혼합하고 환류교반하였다. 24시간 후 MC로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 5 (수율 82%)를 얻었다.Compound 5-2 (22.00g, 0.08mol), Compound 5-3 (33.65g, 0.10mol), Pd (PPh 3 ) 4 (2.65g, 0.002mol), K 2 CO 3 (21.14 g, 0.15 mol), THF (66 mL) and water (22 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with acetone to obtain compound 5 (yield 82%).
1H NMR (CDCl3) δ [ppm]: 9.30(s, 1H), 9.05(d, 1H), 8.86(d, 1H), 8.78(t, 2H), 8.60(dd, 1H), 8.38(d, 1H), 8.32(t, 2H), 8.07(s, 1H), 8.02(d, 1H), 7.78(t, 2H), 7.68(m, 4H), 7.47(q, 1H); MALDI-TOF MS: m/z 467.08, cal. 466.56
1 H NMR (CDCl 3 ) δ [ppm]: 9.30 (s, 1H), 9.05 (d, 1H), 8.86 (d, 1H), 8.78 (t, 2H), 8.60 (dd, 1H), 8.38 (d , 1H), 8.32 (t, 2H), 8.07 (s, 1H), 8.02 (d, 1H), 7.78 (t, 2H), 7.68 (m, 4H), 7.47 (q, 1H); MALDI-TOF MS: m / z 467.08, cal. 466.56
[제조예 6] 화합물 6의 제조Preparation Example 6 Preparation of
화합물 compound 6-16-1 의 제조Manufacturing
0℃에서 N1-페닐벤젠-1,2-디아민 (48g, 260mmol)을 DMAC (N,N-Dimethyl acetamide) (100mL)에 완전히 용해한 후, 4-브로모벤조일클로라이드 (63g, 287mmol)을 적가하고 교반하였다. 2시간 30분 후 피리딘 (60mL)와 물 (100mL)을 투입하였다. 30분간 더 교반한 후 생성된 고체를 메탄올로 씻어주면서 여과하여 흰색의 고체 화합물 6-1 (95g, 수율95%)를 얻었다.After completely dissolving N 1 -phenylbenzene-1,2-diamine (48 g, 260 mmol) in DMAC (N, N-dimethyl acetamide) (100 mL) at 0 ° C., 4-bromobenzoyl chloride (63 g, 287 mmol) was added dropwise. And stirred. After 2 hours and 30 minutes, pyridine (60 mL) and water (100 mL) were added thereto. After further stirring for 30 minutes, the resulting solid was filtered with washing with methanol to obtain a white solid compound 6-1 (95 g, yield 95%).
화합물compound 6-2 6-2 의 제조Manufacturing
화합물 6-1 (95g, 258mmol), PTSA(p-Toluene solfonic acid) (89g, 516mmol)와 톨루엔 (1144mL)를 혼합하고 질소 분위기에서 용매회수장치 (Dean-stark trap) 를 이용하여 환류교반시켰다. 6시간 후 반응물을 농축하고, 메틸렌클로라이드(MC)로 유기층을 추출하였다. 얻어진 반응물을 실리카 필터 후 농축하여, Hexane:MC=8:2 용액 하에서 초음파 처리 (sonicate)하여, 결정화시킨 다음 여과하여 노란색 고체 화합물 6-2 (85g, 수율 94%)를 얻었다.Compound 6-1 (95g, 258mmol), PTSA (p-Toluene solfonic acid) (89g, 516mmol) and toluene (1144mL) were mixed and stirred under reflux using a solvent recovery device (Dean-stark trap) in a nitrogen atmosphere. After 6 hours the reaction was concentrated and the organic layer was extracted with methylene chloride (MC). The resulting reaction was concentrated after silica filter, sonicated under Hexane: MC = 8: 2 solution, crystallized and filtered to give a yellow solid Compound 6-2 (85 g, yield 94%).
1H NMR (CDCl3) δ [ppm]: 8.24(d, 1H), 7.66(m, 3H), 7.62-7.46(m, 6H), 7.40(m, 2H), 7.32(d, 2H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.24 (d, 1H), 7.66 (m, 3H), 7.62-7.46 (m, 6H), 7.40 (m, 2H), 7.32 (d, 2H)
화합물compound 6-3 6-3 의 제조Manufacturing
화합물 6-2 (38.6g, 110mmol), KOAc (32.4g, 330mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (36.5g, 143mmol), 다이옥산 (390mL)과 PdCl2(dppf) (1.8g, 2mmol)을 혼합하고 80℃에서 3시간 동안 교반한 후 20℃로 냉각하였다. 상기 반응물에 물 (400mL)를 투입하고 교반하였다. 교반이 완료되면 MC로 유기층을 추출하고 감압 농축하고, 얻어진 잔사를 EA에 완전히 녹이고 석유에테르를 적가하여 결정화하여 노란색 고체 화합물 6-3 (36g, 수율 82%)를 얻었다.Compound 6-2 (38.6g, 110mmol), KOAc (32.4g, 330mmol), bis (pinacolato) diboron (Bis (pinacolato) diboron) (36.5g, 143mmol), dioxane (390mL) and PdCl 2 (dppf ) (1.8 g, 2 mmol) was mixed and stirred at 80 ° C. for 3 hours and then cooled to 20 ° C. Water (400 mL) was added to the reaction and stirred. After stirring was complete, the organic layer was extracted with MC, concentrated under reduced pressure, and the obtained residue was completely dissolved in EA, and crystallized by dropwise addition of petroleum ether to obtain a yellow solid compound 6-3 (36 g, yield 82%).
1H NMR (CDCl3) δ [ppm]: 7.92(d, 1H), 7.76(d, 2H), 7.59(d, 2H), 7.56-7.45(m, 3H), 7.41-7.29(m, 4H), 7.27(s, 1H), 1.35(s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 7.92 (d, 1H), 7.76 (d, 2H), 7.59 (d, 2H), 7.56-7.45 (m, 3H), 7.41-7.29 (m, 4H) , 7.27 (s, 1H), 1.35 (s, 12H)
화합물
화합물 6-3 (18g, 1.045mol), 9-브로모-6b,12a-디하이드로아세나프토[1,2-b]퀴녹살린 (13.6g, 0.0408mol), Pd2(dba)3 (0.8g, 0.00087mol), PPh3 (1.1g, 0.00419mol), K2CO3 (11.5g, 0.0833mol), THF (200mL)과 물 (100mL)를 혼합하고 환류교반하였다. 반응이 종료되면 MC로 유기층을 추출하고 감압 농축하여 얻어진 노란색의 생성물을 재결정화하여 노란색 고체 화합물 6 (17.9g, 수율 84%)을 얻었다.Compound 6-3 (18g, 1.045mol), 9-bromo-6b, 12a-dihydroacenaphtho [1,2-b] quinoxaline (13.6g, 0.0408mol), Pd 2 (dba) 3 (0.8 g, 0.00087 mol), PPh 3 (1.1 g, 0.00419 mol), K 2 CO 3 (11.5 g, 0.0833 mol), THF (200 mL) and water (100 mL) were mixed and refluxed. When the reaction was completed, the organic layer was extracted with MC and concentrated under reduced pressure to recrystallize the yellow product obtained to give a yellow solid compound 6 (17.9g, 84% yield).
1H NMR (CDCl3) δ [ppm]: 8.48(m, 3H), 8.30(d, 1H), 8.17(dd, 2H), 8.06(dd, 1H), 7.95(s, 1H), 7.89(t, 2H), 7.79(q, 4H), 7.64-7.53(m, 3H), 7.47-7.37(m, 3H), 7.32(m, 2H); MALDI-TOF MS: m/z 522.18, cal. 523.16
1 H NMR (CDCl 3 ) δ [ppm]: 8.48 (m, 3H), 8.30 (d, 1H), 8.17 (dd, 2H), 8.06 (dd, 1H), 7.95 (s, 1H), 7.89 (t , 2H), 7.79 (q, 4H), 7.64-7.53 (m, 3H), 7.47-7.37 (m, 3H), 7.32 (m, 2H); MALDI-TOF MS: m / z 522.18, cal. 523.16
[제조예 7] 화합물 7의 제조Preparation Example 7 Preparation of
화합물compound 7-1 7-1 의 제조Manufacturing
2,4,6-트리클로로피리미딘 (26g, 0.1417 mol), 1-나프틸보론산 (24.4g, 0.1421 mol), Pd(PPh3)4 (0.001 mol, 1.65g), 2M K2CO3 수용액 (200mL)과 THF (390mL)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 EA로 유기층을 추출하고 에테르로 씻어내면서 초음파 처리(Sonicate)하면서 결정화시켜 흰색의 고체 화합물 7-1 (23.2g, 수율 61%)을 얻었다.2,4,6-trichloropyrimidine (26g, 0.1417 mol), 1-naphthylboronic acid (24.4g, 0.1421 mol), Pd (PPh 3 ) 4 (0.001 mol, 1.65g), 2M K 2 CO 3 Aqueous solution (200 mL) and THF (390 mL) were mixed and stirred under reflux for 12 hours. After completion of the reaction, the organic layer was extracted with EA, washed with ether, sonicated (Sonicate) and crystallized to obtain a white solid compound 7-1 (23.2g, 61% yield).
1H NMR (CDCl3) δ [ppm]: 8.18(m, 1H), 8.04(d, 1H), 7.97(m, 1H), 7.73(dd, 1H), 7.65(s, 1H), 7.64-7.56(m, 3H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.18 (m, 1 H), 8.04 (d, 1 H), 7.97 (m, 1 H), 7.73 (dd, 1 H), 7.65 (s, 1 H), 7.64-7.56 (m, 3 H)
화합물compound 7-2 7-2 의 제조Manufacturing
화합물 7-1 (16.5g, 0.0599 mol), 9,9-디메틸-9H-플루오렌-2-일-2-보론산 (15g, 0.0629 mol), Pd(PPh3)4 (0.7g, 0.000605mol), 2M K2CO3 수용액 (124mL)와 THF (248mL)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 EA로 유기층을 추출하고 에테르로 씻어내면서 초음파 처리(Sonicate)하면서 결정화시켜 흰색의 고체 화합물 7-2 (22.8g, 수율 88%)을 얻었다.Compound 7-1 (16.5g, 0.0599 mol), 9,9-dimethyl-9H-fluoren-2-yl-2-boronic acid (15g, 0.0629 mol), Pd (PPh 3 ) 4 (0.7g, 0.000605mol ), 2M K 2 CO 3 aqueous solution (124 mL) and THF (248 mL) were mixed and stirred under reflux for 12 hours. After completion of the reaction, the organic layer was extracted with EA, washed with ether, sonicated (Sonicate) and crystallized to obtain a white solid compound 7-2 (22.8g, yield 88%).
1H NMR (CDCl3) δ [ppm]: 8.29(d, 1H), 8.22(t, 1H), 8.16(dd, 1H), 8.04(d, 1H), 8.01(s, 1H), 7.98(t, 1H), 7.88(d, 1H), 7.83(m, 1H), 7.79(dd, 1H), 7.65(m, 1H), 7.60(m, 2H), 7.51(m, 1H), 7.62(m, 2H), 1.59(s, 6H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.29 (d, 1H), 8.22 (t, 1H), 8.16 (dd, 1H), 8.04 (d, 1H), 8.01 (s, 1H), 7.98 (t , 1H), 7.88 (d, 1H), 7.83 (m, 1H), 7.79 (dd, 1H), 7.65 (m, 1H), 7.60 (m, 2H), 7.51 (m, 1H), 7.62 (m, 2H), 1.59 (s, 6H)
화합물compound 7-3 7-3 의 제조Manufacturing
화합물 4-2 (40g, 202mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (53.86g, 212mmol), 1,4-다이옥산 (480mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (1.65g, 2mmol)과 CH3CO2K (39.65g, 404mmol)을 혼합하고 환류교반하였다. 9시간 후 20℃로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 핵산에 녹인 후 다시 여과하고 농축하였다. 농축된 잔사를 다시 EA에 녹인 후 실리카겔 여과 후 농축하여 얻어진 갈색 액체를 상온에서 방치하여 갈색 고체 화합물 7-3 (49.5g, 수율 99%)을 얻었다.Compound 4-2 (40g, 202mmol), Bis (pinacolato) diboron (53.86g, 212mmol), 1,4-dioxane (480mL), 1,1'-bis (diphenyl Phosino) ferrocene-palladium (II) dichloride dichloromethane complex (1.65 g, 2 mmol) and CH 3 CO 2 K (39.65 g, 404 mmol) were mixed and refluxed. After 9 hours, the mixture was cooled to 20 ° C., saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , treated with activated carbon, and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was dissolved in nucleic acid, filtered and concentrated again. The concentrated residue was dissolved in EA again, filtered through silica gel, and concentrated. The resulting brown liquid was left at room temperature to obtain a brown solid compound 7-3 (49.5 g, 99% yield).
1H NMR (CDCl3) δ [ppm]: 8.97(s, 1H), 8.37(s, 1H), 7.79(q, 2H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.97 (s, 1 H), 8.37 (s, 1 H), 7.79 (q, 2 H)
화합물
화합물 7-2 (21.2g, 0.0489 mol), 화합물 7-3 (19.3g, 0.0787mol), Pd(PPh3)4 (0.66g, 0.000571mol), 2M K2CO3 수용액 (133mL)과 THF (265mL)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 EA로 유기층을 추출하고 에테르로 씻어내면서 초음파 처리(Sonicate)하면서 결정화시켜 흰색의 고체 화합물 7 (18.2g, 수율 72%)을 얻었다.Compound 7-2 (21.2 g, 0.0489 mol), Compound 7-3 (19.3 g, 0.0787 mol), Pd (PPh 3 ) 4 (0.66 g, 0.000571 mol), 2M K 2 CO 3 aqueous solution (133 mL) and THF ( 265 mL) were stirred and refluxed for 12 h. After completion of the reaction, the organic layer was extracted with EA, washed with ether, sonicated (Sonicate) and crystallized to obtain a white solid compound 7 (18.2g, 72% yield).
1H NMR (CDCl3) δ [ppm]: 10.00(s, 1H), 8.85(dd, 1H), 8.48(s, 1H), 8.39-8.31(m, 3H), 8.09-8.01(m, 3H), 7.93(q, 2H), 7.87(m, 2H), 7.71(t, 1H), 7.62(m, 2H), 7.54(m, 1H), 7.42(m, 2H), 1.64(s, 6H); MALDI-TOF MS: m/z 515.64, cal. 515.21
1 H NMR (CDCl 3 ) δ [ppm]: 10.00 (s, 1H), 8.85 (dd, 1H), 8.48 (s, 1H), 8.39-8.31 (m, 3H), 8.09-8.01 (m, 3H) , 7.93 (q, 2H), 7.87 (m, 2H), 7.71 (t, 1H), 7.62 (m, 2H), 7.54 (m, 1H), 7.42 (m, 2H), 1.64 (s, 6H); MALDI-TOF MS: m / z 515.64, cal. 515.21
[제조예 8] 화합물 8의 제조Preparation Example 8 Preparation of
화합물compound 8-1 8-1 의 제조Manufacturing
2,4,6-트리클로로피리미딘 (50g, 272.6mmol), 9,9-디메틸-9H-플루오렌-2-일2-보론산 (129.81g, 545.2mmol), THF (750mL), Pd(PPh3)4 (6.3g, 5.5mol)와 2M K2CO3 수용액 (375mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 오일을 진공 건조하여 폼 형태의 고체 화합물 8-1 (136g, 수율 100%)을 얻었다. 2,4,6-trichloropyrimidine (50 g, 272.6 mmol), 9,9-dimethyl-9H-fluoren-2-yl2-boronic acid (129.81 g, 545.2 mmol), THF (750 mL), Pd ( PPh 3 ) 4 (6.3 g, 5.5 mol) and 2M K 2 CO 3 aqueous solution (375 mL) were mixed and stirred under reflux for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the oil thus obtained was vacuum dried to obtain a solid compound 8-1 (136 g, yield 100%) in the form of a foam.
1H NMR (CDCl3) δ [ppm]: 8.29 (d, 2H), 8.18-8.16 (d, 2H), 8.12 (s, 1H), 7.9 (d, 2H), 7.84-7.82 (m, 2H), 7.53-7.51 (m, 2H), 7.44-7.41 (m, 4H), 1.62 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.29 (d, 2H), 8.18-8.16 (d, 2H), 8.12 (s, 1H), 7.9 (d, 2H), 7.84-7.82 (m, 2H) , 7.53-7.51 (m, 2H), 7.44-7.41 (m, 4H), 1.62 (s, 12H)
화합물
화합물 8-1 (30g, 60.1mmol), 화합물 7-3 (22.1g, 90mmol), THF (450mL), Pd(PPh3)4 (1.39g, 1.2mol)와 2M K2CO3 수용액 (225mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하여 화합물 8 (20.3g, 수율 58%)을 얻었다.Compound 8-1 (30 g, 60.1 mmol), Compound 7-3 (22.1 g, 90 mmol), THF (450 mL), Pd (PPh 3 ) 4 (1.39 g, 1.2 mol) with 2M K 2 CO 3 aqueous solution (225 mL) Were mixed and stirred at reflux for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was suspended while heating with ethyl acetate, and then filtered to obtain compound 8 (20.3 g, yield 58%).
1H NMR (CDCl3) δ [ppm]: 10.04 (s, 1H), 8.97-8.94 (d, 1H), 8.49 (s, 1H), 8.39 (s, 2H), 8.32-8.30 (d, 2H), 8.18 (s, 1H), 7.93 (t, 3H), 7.88-7.85 (m, 2H), 7.55-7.52 (m, 2H), 7.45-7.43 (m, 4H), 1.67 (s, 12H); LC-MS:m/z 581.92, cal. 581.71
1 H NMR (CDCl 3 ) δ [ppm]: 10.04 (s, 1H), 8.97-8.94 (d, 1H), 8.49 (s, 1H), 8.39 (s, 2H), 8.32-8.30 (d, 2H) , 8.18 (s, 1H), 7.93 (t, 3H), 7.88-7.85 (m, 2H), 7.55-7.52 (m, 2H), 7.45-7.43 (m, 4H), 1.67 (s, 12H); LC-MS: m / z 581.92, cal. 581.71
[제조예 9] 화합물 9의 제조 Preparation Example 9 Preparation of Compound 9
화합물compound 9- 9- 1 One 의of 제조 Produce
2,4,6-트리클로로피리미딘 (18g, 98.1mmol), 4-(나프탈렌-4-일)페닐보론산 (24.35g, 98mmol), THF (270mL), Pd(PPh3)4 (1.13g, 1mol)와 2M K2CO3 수용액 (135mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 고체를 재결정하여(EA/Hexane) 화합물 9-1 (21g, 수율 60%)을 얻었다. 2,4,6-trichloropyrimidine (18g, 98.1mmol), 4- (naphthalen-4-yl) phenylboronic acid (24.35g, 98mmol), THF (270mL), Pd (PPh 3 ) 4 (1.13g , 1 mol) and 2M K 2 CO 3 aqueous solution (135 mL) were mixed and refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The obtained solid was recrystallized (EA / Hexane) Compound 9-1 (21 g, yield 60 %) Was obtained.
1H NMR (CDCl3) δ [ppm]: 8.24-8.22 (d, 2H), 7.97-7.88 (m, 3H), 7.78 (s, 1H), 7.71-7.69 (d, 2H), 7.60-7.53 (m, 2H), 7.51-7.47 (m, 2H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.24-8.22 (d, 2H), 7.97-7.88 (m, 3H), 7.78 (s, 1H), 7.71-7.69 (d, 2H), 7.60-7.53 ( m, 2H), 7.51-7.47 (m, 2H)
화합물compound 9- 9- 2 2 의of 제조 Produce
화합물 9-1 (20g, 55.4mmol), 9,9-디메틸-9H-플루오렌-2-일-2-보론산 (13.84g, 98mmol), THF (300mL), Pd(PPh3)4 (0.64g, 0.55mol)와 2M K2CO3 수용액 (150mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 오일에 에틸아세테이트를 첨가하여 고체를 석출시켰다. 생성된 고체를 여과하고 에틸아세테이트로 세척하여 화합물 9-2 (19g, 수율 67%)을 얻었다. Compound 9-1 (20g, 55.4mmol), 9,9-dimethyl-9H-fluoren-2-yl-2-boronic acid (13.84g, 98mmol), THF (300mL), Pd (PPh 3 ) 4 (0.64 g, 0.55 mol) and 2M K 2 CO 3 aqueous solution (150 mL) were mixed and stirred under reflux for 18 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. Ethyl acetate was added to the resulting oil to precipitate a solid. The resulting solid was filtered and washed with ethyl acetate to give compound 9-2 (19g, 67% yield).
1H NMR (CDCl3) δ [ppm]: 8.34-8.32 (d, 2H), 8.3 (d, 1H), 8.2-8.18 (d, 2H), 7.97-7.93 (m, 3H), 7.91-7.89 (d, 1H), 7.85-7.82 (m, 1H), 7.74-7.77 (d, 2H), 7.61-7.57 (t, 1H), 7.56-7.47 (m, 4H), 7.43-7.41 (m, 2H), 1.62 (s, 6H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.34-8.32 (d, 2H), 8.3 (d, 1H), 8.2-8.18 (d, 2H), 7.97-7.93 (m, 3H), 7.91-7.89 ( d, 1H), 7.85-7.82 (m, 1H), 7.74-7.77 (d, 2H), 7.61-7.57 (t, 1H), 7.56-7.47 (m, 4H), 7.43-7.41 (m, 2H), 1.62 (s, 6 H)
화합물compound 9 9 의of 제조 Produce
화합물 9-2 (18g, 35.4 mmol), 화합물 7-3 (22.10g, 90 mmol), THF (450mL), Pd(PPh3)4 (1.39g, 1.2mol)와 2M K2CO3 수용액 (225mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하고 에틸아세테이트로 세척하여 화합물 9 (14.8g, 수율 70%)을 얻었다.Compound 9-2 (18 g, 35.4 mmol), Compound 7-3 (22.10 g, 90 mmol), THF (450 mL), Pd (PPh 3 ) 4 (1.39 g, 1.2 mol) with 2M K 2 CO 3 aqueous solution (225 mL ) Was mixed and refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was suspended with ethyl acetate, filtered and washed with ethyl acetate to obtain compound 9 (14.8 g, yield 70%).
1H NMR (CDCl3) δ [ppm]: 10.05 (s, 1H), 8.98-8.95 (d, 1H), 8.49 (s, 2H), 8.48-4.46 (d, 1H), 8.39 (s, 1H), 8.31 (d, 1H), 8.23 (s, 1H), 7.99-7.93 (m, 5H), 7.90-7.81 (m, 1H), 7.78-7.76 (d, 2H), 7.61-7.44 (m, 5H), 7.43-7.38 (m, 2H), 1.67 (s, 6H); MALDI-TOF MS: m/z 591.5, cal. 591.7
1 H NMR (CDCl 3 ) δ [ppm]: 10.05 (s, 1H), 8.98-8.95 (d, 1H), 8.49 (s, 2H), 8.48-4.46 (d, 1H), 8.39 (s, 1H) , 8.31 (d, 1H), 8.23 (s, 1H), 7.99-7.93 (m, 5H), 7.90-7.81 (m, 1H), 7.78-7.76 (d, 2H), 7.61-7.44 (m, 5H) , 7.43-7.38 (m, 2 H), 1.67 (s, 6 H); MALDI-TOF MS: m / z 591.5, cal. 591.7
[제조예 10] 화합물 10의 제조 Preparation Example 10 Preparation of Compound 10
화합물 8-1 (60.1 mmol), 화합물 5-3 (20.94g, 62 mmol), THF (450mL), Pd(PPh3)4 (1.39g, 1.2mol)와 2M K2CO3 수용액 (225mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 오일에 에틸아세테이트를 첨가하여 고체를 석출시켰다. 생성된 고체를 재결정(디클로로메탄:에틸아세테이트)하여 화합물 10 (20g, 수율 50%)을 얻었다. Compound 8-1 (60.1 mmol), Compound 5-3 (20.94 g, 62 mmol), THF (450 mL), Pd (PPh 3 ) 4 (1.39 g, 1.2 mol) and 2M K 2 CO 3 aqueous solution (225 mL) The mixture was stirred at reflux for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and ethyl acetate was added to the oil obtained to precipitate a solid. The resulting solid was recrystallized (dichloromethane: ethyl acetate) to give compound 10 (20 g, yield 50%).
1H NMR (CDCl3) δ [ppm]: 8.48 (t, 1H), 8.97-8.95 (d, 1H), 8.64-8.62 (d, 1H), 8.4(s, 2H), 8.37 (t, 1H), 8.35 (t, 3H), 8.17 (s, 1H), 7.95-7.93 (d, 2H), 7.86-7.84 (m, 2H), 7.76 (t, 1H), 7.55-7.53 (m, 2H), 7.51-7.48 (q, 1H), 7.45-7.41 (m, 4H), 1.68 (s, 12H); MALDI-TOF MS: m/z 675.37, cal. 674.85.
1 H NMR (CDCl 3 ) δ [ppm]: 8.48 (t, 1H), 8.97-8.95 (d, 1H), 8.64-8.62 (d, 1H), 8.4 (s, 2H), 8.37 (t, 1H) , 8.35 (t, 3H), 8.17 (s, 1H), 7.95-7.93 (d, 2H), 7.86-7.84 (m, 2H), 7.76 (t, 1H), 7.55-7.53 (m, 2H), 7.51 -7.48 (q, 1 H), 7.45-7.41 (m, 4 H), 1.68 (s, 12 H); MALDI-TOF MS: m / z 675.37, cal. 674.85.
[제조예 11] 화합물 11의 제조Preparation Example 11 Preparation of Compound 11
화합물compound 11- 11- 1 One 의of 제조 Produce
2,4,6-트리클로로피리미딘 (50g, 272.6mmol), 9,9-디메틸-9H-플루오렌-2-일-2-보론산 (64.9g, 273mmol), THF (750mL), Pd(PPh3)4 (3.15g, 2.7mmol)와 2M K2CO3 수용액 (375mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 오일에 에틸아세테이트를 첨가하여 고체를 석출시켰다. 생성된 고체를 재결정하여 화합물 11-1 (109g, 수율 100%)을 얻었다. 2,4,6-trichloropyrimidine (50 g, 272.6 mmol), 9,9-dimethyl-9H-fluoren-2-yl-2-boronic acid (64.9 g, 273 mmol), THF (750 mL), Pd ( PPh 3 ) 4 (3.15 g, 2.7 mmol) and 2M K 2 CO 3 aqueous solution (375 mL) were mixed and stirred under reflux for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and ethyl acetate was added to the oil obtained to precipitate a solid. The resulting solid was recrystallized to give compound 11-1 (109 g, 100% yield).
1H NMR (CDCl3) δ [ppm]: 8.18 (d, 1H), 8.09-8.07 (d, 1H), 7.87-7.85 (d, 1H), 7.83-7.80 (m, 1H), 7.75 (s, 1H), 7.52-7.50 (m, 1H), 7.43-7.41 (m, 2H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.18 (d, 1 H), 8.09-8.07 (d, 1 H), 7.87-7.85 (d, 1 H), 7.83-7.80 (m, 1 H), 7.75 (s, 1H), 7.52-7.50 (m, 1H), 7.43-7.41 (m, 2H)
화합물compound 11- 11- 2 2 의of 제조 Produce
화합물 5-1 (30.9g, 90.6mmol), 화합물 11-1 (91mmol), THF (500mL), Pd(PPh3)4 (1.05g, 0.91mmol)와 2M K2CO3 수용액 (250mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 오일 형태의 화합물 11-2 (44g, 수율 100%)을 얻었다. Mix compound 5-1 (30.9 g, 90.6 mmol), compound 11-1 (91 mmol), THF (500 mL), Pd (PPh 3 ) 4 (1.05 g, 0.91 mmol) with 2M K 2 CO 3 aqueous solution (250 mL) And refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The resulting filtrate was concentrated under reduced pressure to give compound 11-2 (44 g, yield 100%) in the form of an oil.
1H NMR (CDCl3) δ [ppm]: 9.44 (s, 1H), 8.93-8.87 (q, 2H), 8.82-8.80 (d, 1H), 8.43-8.41 (d, 2H), 8.14 (s, 1H), 8.10 (s, 1H), 8.07-8.05 (d, 1H), 7.86-7.84 (m, 1H), 7.81-7.76 (q, 2H), 7.74-7.70 (m, 3H), 7.43-7.41 (m, 2H), 1.65 (s, 6H) 1 H NMR (CDCl 3 ) δ [ppm]: 9.44 (s, 1 H), 8.93-8.87 (q, 2 H), 8.82-8.80 (d, 1 H), 8.43-8.41 (d, 2H), 8.14 (s, 1H), 8.10 (s, 1H), 8.07-8.05 (d, 1H), 7.86-7.84 (m, 1H), 7.81-7.76 (q, 2H), 7.74-7.70 (m, 3H), 7.43-7.41 ( m, 2H), 1.65 (s, 6H)
화합물compound 11 11 의of 제조 Produce
화합물 11-2 (40g, 82.8mmol), 화합물 5-3 (28.01g, 83mmol), THF (600mL), Pd(PPh3)4 (1.91g, 1.66mmol)와 2M K2CO3 수용액 (300mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 오일에 에틸아세테이트로 가열하면서 현탁시킨 후 여과하고 에틸아세테이트로 세척하여 화합물 11 (28g, 수율 51%)을 얻었다.Compound 11-2 (40 g, 82.8 mmol), Compound 5-3 (28.01 g, 83 mmol), THF (600 mL), Pd (PPh 3 ) 4 (1.91 g, 1.66 mmol) and 2M K 2 CO 3 aqueous solution (300 mL) The mixture was stirred and refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The filtrate was concentrated under reduced pressure, suspended in an oil obtained by heating with ethyl acetate, filtered and washed with ethyl acetate to obtain compound 11 (28 g, yield 51%).
1H NMR (CDCl3) δ [ppm]: 9.44 (s, 1H), 8.93-8.87 (q, 2H), 8.82-8.80 (d, 1H), 8.62-8.61 (d, 1H), 8.46 (s, 1H), 8.43-8.33 (m, 4H), 8.14 (s, 1H), 8.10 (s, 1H), 8.07-8.05 (d, 1H), 7.96-7.94 (d, 1H), 7.86-7.84 (m, 1H), 7.81-7.76 (q, 2H), 7.74-7.70 (m, 3H), 7.53-7.49 (m, 1H),7.48-7.44 (q, 1H), 7.43-7.41 (m, 2H), 1.65 (s, 6H); MALDI-TOF MS: m/z 658.12, cal. 658.81
1 H NMR (CDCl 3 ) δ [ppm]: 9.44 (s, 1 H), 8.93-8.87 (q, 2 H), 8.82-8.80 (d, 1 H), 8.62-8.61 (d, 1H), 8.46 (s, 1H), 8.43-8.33 (m, 4H), 8.14 (s, 1H), 8.10 (s, 1H), 8.07-8.05 (d, 1H), 7.96-7.94 (d, 1H), 7.86-7.84 (m, 1H), 7.81-7.76 (q, 2H), 7.74-7.70 (m, 3H), 7.53-7.49 (m, 1H), 7.48-7.44 (q, 1H), 7.43-7.41 (m, 2H), 1.65 ( s, 6H); MALDI-TOF MS: m / z 658.12, cal. 658.81
[제조예 12] 화합물 12의 제조Preparation Example 12 Preparation of Compound 12
1-브로모파이렌 (20g, 0.07mol), 화합물 5-3 (37.21g, 0.11mol), THF (380mL), Pd(PPh3)4 (0.97g, 0.84mmol)와 2M K2CO3 수용액 (188mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 오일에 에틸아세테이트를 가하여 녹인 후 실리카겔 여과하고 여액을 감압 농축하였다. 농축하여 얻어진 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하고 에틸아세테이트로 세척하여 화합물 12 (14.5g, 수율 50%)을 얻었다.1-bromopyrene (20g, 0.07mol), compound 5-3 (37.21g, 0.11mol), THF (380mL), Pd (PPh 3 ) 4 (0.97g, 0.84mmol) and 2M K 2 CO 3 aqueous solution (188 mL) was mixed and stirred at reflux for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The resulting filtrate was concentrated under reduced pressure, ethyl acetate was added to the oil, and the resulting filtrate was dissolved in silica gel. The filtrate was concentrated under reduced pressure. The solid obtained by concentration was suspended with heating with ethyl acetate, filtered and washed with ethyl acetate to obtain compound 12 (14.5 g, yield 50%).
1H NMR (CDCl3) δ [ppm]: 8.68 (dd, 1H), 8.46 (d, 1H), 8.31-8.04 (d, 1H), 7.78-7.61 (m, 4H), 7.86-7.54 (m, 5H), 7.38 (m, 2H), 7.16 (m, 2H); MALDI-TOF MS: m/z 412.34, cal. 412.51
1 H NMR (CDCl 3 ) δ [ppm]: 8.68 (dd, 1H), 8.46 (d, 1H), 8.31-8.04 (d, 1H), 7.78-7.61 (m, 4H), 7.86-7.54 (m, 5H), 7.38 (m, 2 H), 7.16 (m, 2 H); MALDI-TOF MS: m / z 412.34, cal. 412.51
[제조예 13] 화합물 13의 제조Preparation Example 13 Preparation of Compound 13
화합물 compound 13-113-1 의 제조Manufacturing
메틸렌클로라이드 (64mL)와 4-브로모벤조일클로라이드 (50g, 0.2278mol)을 혼합하고 -10℃에서 교반하였다. 4-브로모벤조일클로라이드를 완전히 용해한 후 피리딘 (220mL)과 2-클로로피리딘-3-아민 (26.6g, 0.2069mol)의 혼합용액을 천천히 적가하였다. 2시간 30동안 교반한 다음, 물 (2500mL)을 투입하고 생성된 고체를 여과하고, 메탄올로 씻어주어 흰색 고체 화합물 13-1 (54.8g, 수율 85%)을 얻었다. Methylene chloride (64 mL) and 4-bromobenzoyl chloride (50 g, 0.2278 mol) were mixed and stirred at -10 ° C. After 4-bromobenzoyl chloride was completely dissolved, a mixed solution of pyridine (220 mL) and 2-chloropyridin-3-amine (26.6 g, 0.2069 mol) was slowly added dropwise. After stirring for 2 hours 30, water (2500 mL) was added thereto, and the resulting solid was filtered and washed with methanol to obtain a white solid compound 13-1 (54.8 g, yield 85%).
화합물 compound 13-213-2 의 제조Manufacturing
1,3-디메틸-3,4,5,6-테트라하이드로-2(1H)-피리미디논(DMPU) (45mL), 화합물 13-1 (9g, 0.0288 mol)과 로슨시약 (11.7g)을 혼합하고 2시간 30분 동안 환류교반하였다. 반응이 완료되면 에틸아세테이트(EA)로 유기층을 추출하고 농축하여 연한 노란색의 고체 화합물 13-2 (24g, 수율 80%)을 얻었다.1,3-dimethyl-3,4,5,6-tetrahydro-2 (1H) -pyrimidinone (DMPU) (45 mL), compound 13-1 (9 g, 0.0288 mol) and Lawson reagent (11.7 g) Mix and stir at reflux for 2 hours 30 minutes. When the reaction was completed, the organic layer was extracted with ethyl acetate (EA) and concentrated to give a pale yellow solid compound 13-2 (24g, 80% yield).
화합물 compound 13-313-3 의 제조Manufacturing
화합물 13-2 (27.47g, 103mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (27.47g, 108mmol), 1,4-다이옥산 (450mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (1.68g, 2.1mmol과 CH3CO2K (20.22g, 206.1mmol)을 혼합하고 환류교반하였다. 12시간 후 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 핵산에 현탁 교반하고, 여과한 후, 핵산으로 세척하여 화합물 13-3 (41.8g, 수율 89 %)를 얻었다.Compound 13-2 (27.47 g, 103 mmol), bis (pinacolato) diboron (27.47 g, 108 mmol), 1,4-dioxane (450 mL), 1,1'-bis (di Phenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1.68 g, 2.1 mmol and CH 3 CO 2 K (20.22 g, 206.1 mmol) was mixed and stirred under reflux. After 12 h, cooled to room temperature and saturated NaCl Aqueous solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , activated charcoal treatment, and filtered through Celite, the resulting filtrate was concentrated under reduced pressure, suspended and stirred with nucleic acid, filtered and washed with nucleic acid. Compound 13-3 (41.8g, yield 89%) was obtained.
화합물 compound 1313 의 제조Manufacturing
화합물 13-3 (27.70g, 55.5mmol), 화합물 8-1 (19.4g, 57.3mmol), Pd(PPh3)4 (1.32g, 1.14mmol), 2M K2CO3 수용액 (204mL), THF (408mL)와 물 (136mL)를 혼합하고 환류교반하였다. 24시간 후 MC로 유기층을 추출한 후 감압 농축하고 아세톤으로 씻어주어 화합물 13 (21g, 수율 57%)를 얻었다.Compound 13-3 (27.70 g, 55.5 mmol), Compound 8-1 (19.4 g, 57.3 mmol), Pd (PPh 3 ) 4 (1.32 g, 1.14 mmol), 2M K 2 CO 3 aqueous solution (204 mL), THF ( 408 mL) and water (136 mL) were mixed and stirred under reflux. After 24 hours, the organic layer was extracted with MC, concentrated under reduced pressure, and washed with acetone to obtain compound 13 (21 g, yield 57%).
1H NMR (CDCl3) δ [ppm]: 9.24 (t, 1H), 8.96 (m, 1H), 8.58-8.45 (m, 4H), 8.38 (m, 3H), 8.26 (s, 1H), 8.04 (d, 2H), 7.86 (m, 2H), 7.73 (m, 1H), 7.64-7.51 (m, 3H), 7.45-7.41 (m, 4H), 1.67 (s, 12H); MALDI-TOF MS: m/z 674.61, cal. 674.85
1 H NMR (CDCl 3 ) δ [ppm]: 9.24 (t, 1H), 8.96 (m, 1H), 8.58-8.45 (m, 4H), 8.38 (m, 3H), 8.26 (s, 1H), 8.04 (d, 2H), 7.86 (m, 2H), 7.73 (m, 1H), 7.64-7.51 (m, 3H), 7.45-7.41 (m, 4H), 1.67 (s, 12H); MALDI-TOF MS: m / z 674.61, cal. 674.85
[제조예 14] 화합물 14의 제조Preparation Example 14 Preparation of Compound 14
화합물 compound 14-114-1 의 제조Manufacturing
2,4,6-트리클로로피리미딘 (15g, 81.8mmol), 화합물 5-1 (36.3g, 163mmol), THF (450mL), Pd(PPh3)4 (0.95g, 0.8 mmol)와 1M K2CO3 수용액 (200mL)을 혼합하고 18시간동안 환류교반한 다음, 상온으로 냉각하였다. 상기 반응물을 여과하고 여과된 하얀색 고체를 증류수로 세척하였다. 세척된 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하여 화합물 14-1 (25g, 수율 68%)을 얻었다.2,4,6-trichloropyrimidine (15 g, 81.8 mmol), compound 5-1 (36.3 g, 163 mmol), THF (450 mL), Pd (PPh 3 ) 4 (0.95 g, 0.8 mmol) and 1 M K 2 Aqueous CO 3 solution (200 mL) was mixed and stirred under reflux for 18 hours, then cooled to room temperature. The reaction was filtered and the filtered white solid was washed with distilled water. The washed solid was suspended while heating with ethyl acetate and filtered to give compound 14-1 (25 g, yield 68%).
1H NMR (DMSO-d6) δ [ppm]: 9.01 (d, 2H) 8.95 (d, 2H) 8.43 (d, 2H) 8.34 (d, 2H) 8.15 (d, 2H) 7.84-7.77 (m, 9H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 9.01 (d, 2H) 8.95 (d, 2H) 8.43 (d, 2H) 8.34 (d, 2H) 8.15 (d, 2H) 7.84-7.77 (m, 9H)
화합물 compound 1414 의 제조Manufacturing
화합물 14-1 (24g, 53.7mmol), 화합물 5-3 (21.8g, 64.4mmol), Pd(PPh3)4 (1.86g, 1.6 mmol), 2M K2CO3 수용액 (350mL), 톨루엔 (700mL)와 THF (400mL)를 혼합하고 18시간동안 환류교반한 다음, 상온으로 냉각하였다. 상기 반응물을 여과하고 여과된 고체를 증류수로 세척하였다. 세척된 고체를 톨루엔으로 가열하면서 현탁시킨 후 여과하여 화합물 14 (21.6g, 수율 62%)을 얻었다.Compound 14-1 (24g, 53.7mmol), Compound 5-3 (21.8g, 64.4mmol), Pd (PPh 3 ) 4 (1.86g, 1.6 mmol), 2M K 2 CO 3 aqueous solution (350mL), toluene (700mL) and THF (400mL) were mixed and stirred under reflux for 18 hours, and then cooled to room temperature. The reaction was filtered and the filtered solid was washed with distilled water. The washed solid was suspended with heating with toluene and then filtered to give compound 14 (21.6 g, yield 62%).
1H NMR (DMSO-d6) δ [ppm]: 9.30 (s, 1H) 9.06 (d, 2H) 8.99 (d, 2H) 8.78 (d, 1H) 8.64 (d, 1H) 8.57 (d, 2H) 8.48 (d, 1H) 8.41 (s, 2H) 8.32 (s, 2H) 8.19 (d, 2H) 7.86-7.83 (m, 5H) 7.80-7.75 (m, 4H) 7.61 (m, 1H); LC-MS:m/z 641, cal. 642.77
1 H NMR (DMSO-d 6 ) δ [ppm]: 9.30 (s, 1H) 9.06 (d, 2H) 8.99 (d, 2H) 8.78 (d, 1H) 8.64 (d, 1H) 8.57 (d, 2H) 8.48 (d, 1H) 8.41 (s, 2H) 8.32 (s, 2H) 8.19 (d, 2H) 7.86-7.83 (m, 5H) 7.80-7.75 (m, 4H) 7.61 (m, 1H); LC-MS: m / z 641, cal. 642.77
[제조예 15] 화합물 131의 제조Preparation Example 15 Preparation of Compound 131
화합물 compound 15-115-1 의 제조Manufacturing
9-브로모펜난트렌 (40g, 155.6mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (43.4g, 171mmol), 1,4-다이옥산 (600mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물(1,1'-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex) (2.54g, 3.1mmol)과 CH3CO2K (30.5g, 311.1mmol)을 혼합하고 12시간동안 환류교반하고 상온으로 냉각하였다. 상기 반응물에 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 산성백토처리하고, 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 잔사에 n-헥산을 넣고 교반하였다. 이때 생성된 고체를 여과하고 헥산으로 세척하여 화합물 15-1 (32g, 수율 67%)을 얻었다.9-bromophenanthrene (40 g, 155.6 mmol), bis (pinacolato) diboron (43.4 g, 171 mmol), 1,4-dioxane (600 mL), 1,1'-bis (Diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1,1'-Bis (diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex) (2.54 g, 3.1 mmol) and CH 3 CO 2 K (30.5 g, 311.1 mmol) were mixed, stirred at reflux for 12 hours, and cooled to room temperature. Saturated NaCl solution and ethyl acetate (EA) were added to the reaction mixture. The organic layer was extracted, dried over MgSO 4 , and treated with acidic clay. The filtrate was concentrated under reduced pressure, and n-hexane was added to the residue, which was then stirred. The resulting solid was filtered and washed with hexane to give compound 15-1 (32g, yield 67%).
1H NMR (CDCl3) δ [ppm]: 8.86 (m, 1H) 8.74-8.69 (m, 2H) 8.42 (S, 1H) 7.97 (d, 1H) 7.72-7.59 (m, 4H) 1.49 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.86 (m, 1 H) 8.74-8.69 (m, 2 H) 8.42 (S, 1 H) 7.97 (d, 1 H) 7.72-7.59 (m, 4H) 1.49 (s, 12H)
화합물compound 15- 15- 2 2 의of 제조 Produce
1-브로모-3-아이오도벤젠 (34.2g, 120.8mmol), THF (560mL), 화합물 15-1 (35g, 115.1mmol), Pd(PPh3)4 (1.33g, 1.2mmol)와 1M K2CO3 수용액 (280mL)을 넣고 48시간동안 환류교반하고 상온으로 냉각하였다. 상기 반응물에 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 여과한 후 감압농축하였다. 농축 후 얻어진 오일 잔사를 n-헥산으로 컬럼 정제하여 화합물 15-2 (33.6g, 수율 90%)을 얻었다.1-bromo-3-iodobenzene (34.2 g, 120.8 mmol), THF (560 mL), compound 15-1 (35 g, 115.1 mmol), Pd (PPh 3 ) 4 (1.33 g, 1.2 mmol) and 1 M K 2 CO 3 An aqueous solution (280 mL) was added thereto, and the mixture was stirred under reflux for 48 hours and cooled to room temperature. Saturated NaCl solution and ethyl acetate (EA) were added to the reaction mixture, the organic layer was extracted, dried over MgSO 4 , filtered and concentrated under reduced pressure. The oil residue obtained after concentration was purified by column with n-hexane to give compound 15-2 (33.6g, 90% yield).
1H NMR (CDCl3) δ [ppm]: 8.81 (d, 1H) 8.76 (d, 1H) 7.93-7.87 (m, 2H) 7.74-7.73 (d, 2H) 7.71 (s, 2H) 7.69-7.52 (m, 3H) 7.51 (d, 1H) 7.41 (t, 1H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.81 (d, 1H) 8.76 (d, 1H) 7.93-7.87 (m, 2H) 7.74-7.73 (d, 2H) 7.71 (s, 2H) 7.69-7.52 ( m, 3H) 7.51 (d, 1H) 7.41 (t, 1H)
화합물compound 15- 15- 3 3 의of 제조 Produce
화합물 15-2 (44.9g, 130 mmol), 1,4-다이옥산 (600mL), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (37.7g, 149mmol), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물(1,1'-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex) (2.21g, 2.7mmol)과 CH3CO2K (36.5g, 270.1mmol)을 혼합하고 12시간동안 환류교반한 다음, 상온으로 냉각하였다. 상기 반응물에 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 여과한 후 감압농축하였다. 농축 후 얻어진 고체를 에틸아세테이트와 n-헥산으로 재결정하였다. 생성된 고체를 여과하고 n-헥산으로 세척하여 화합물 15-3 (42g, 수율 81%)을 얻었다.Compound 15-2 (44.9 g, 130 mmol), 1,4-dioxane (600 mL), bis (pinacolato) diboron (37.7 g, 149 mmol), 1,1'-bis ( Diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1,1'-Bis (diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex) (2.21 g, 2.7 mmol) and CH 3 CO 2 K ( 36.5 g, 270.1 mmol) were mixed and refluxed under stirring for 12 hours, and then cooled to room temperature. Saturated NaCl solution and ethyl acetate (EA) were added to the reaction mixture, the organic layer was extracted, dried over MgSO 4 , filtered and concentrated under reduced pressure. The solid obtained after concentration was recrystallized with ethyl acetate and n-hexane. The resulting solid was filtered and washed with n-hexane to give compound 15-3 (42 g, yield 81%).
1H NMR (CDCl3) δ [ppm]: 8.69 (d, 1H) 8.90(d, 1H) 8.07(d, 1H) 7.81 (t, 3H) 7.79-7.67 (m ,5H) 7.63-7.59 (m, 2H) 1.31 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.69 (d, 1H) 8.90 (d, 1H) 8.07 (d, 1H) 7.81 (t, 3H) 7.79-7.67 (m, 5H) 7.63-7.59 (m, 2H) 1.31 (s, 12H)
화합물compound 15- 15- 4 4 의of 제조 Produce
화합물 15-3 (25g, 65.7mmol), 2,4-다이클로로-6-메틸피리미딘 (10.9g, 67.1mmol), THF (370mL), Pd(PPh3)4 (0.76g, 0.7mmol)와 1M K2CO3 수용액 (180 mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 오일 잔사를 에틸아세테이트와 n-헥산으로 컬럼 정제하여 화합물 15-4 (25g, 수율 100%)을 얻었다.Compound 15-3 (25 g, 65.7 mmol), 2,4-dichloro-6-methylpyrimidine (10.9 g, 67.1 mmol), THF (370 mL), Pd (PPh 3 ) 4 (0.76 g, 0.7 mmol) 1 M K 2 CO 3 aqueous solution (180 mL) was mixed and stirred at reflux for 18 h. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The oil residue was purified by column purification with ethyl acetate and n-hexane to obtain Compound 15-4 ( 25 g, yield 100%) was obtained.
1H NMR (CDCl3) δ [ppm]: 8.83 (d, 1H) 8.81 (d, 1H) 8.75 (t, 1H) 8.24 (d, 1H) 7.92 (d, 1H) 7.88 (d, 1H) 7.75-7.59 (m, 6H) 7.55 (t, 2H) 2.60 (s, 3H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.83 (d, 1H) 8.81 (d, 1H) 8.75 (t, 1H) 8.24 (d, 1H) 7.92 (d, 1H) 7.88 (d, 1H) 7.75- 7.59 (m, 6H) 7.55 (t, 2H) 2.60 (s, 3H)
화합물 compound 131 131 의of 제조 Produce
화합물 15-4 (22g, 57.8mmol), 화합물 5-3 (19.5g, 57.8mmol), THF (400mL), Pd(PPh3)4 (1.34g, 1.16 mmol)과 2M K2CO3 수용액 (200mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 석출된 고체를 여과하고, 증류수로 씻어주었다. 얻어진 흰색 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하여 화합물 131 (22g, 수율 68%)을 얻었다.Compound 15-4 (22 g, 57.8 mmol), Compound 5-3 (19.5 g, 57.8 mmol), THF (400 mL), Pd (PPh 3 ) 4 (1.34 g, 1.16 mmol) and 2M K 2 CO 3 aqueous solution (200 mL ) Was mixed and refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, and the precipitated solid was filtered and washed with distilled water. The white solid obtained was suspended while heating with ethyl acetate, and then filtered to obtain compound 131 (22 g, yield 68%).
1H NMR (CDCl3) δ [ppm]: 9.31 (t, 1H) 8.86 (d, 1H) 8.80-8.77 (m, 2H) 8.62 (d, 1H) 8.41 (m, 2H) 8.31 (d, 1H) 8.25 (d, 1H) 8.00-7.96 (m, 2H) 7.82 (s, 1H) 7.76-7.71 (m, 4H) 7.69-7.66 (m, 2H) 7.60-7.58 (m, 2H) 7.48-7.45 (m, 1H) 2.72 (s, 3H); MALDI-TOF MS: m/z 556.8, cal. 556.68
1 H NMR (CDCl 3 ) δ [ppm]: 9.31 (t, 1H) 8.86 (d, 1H) 8.80-8.77 (m, 2H) 8.62 (d, 1H) 8.41 (m, 2H) 8.31 (d, 1H) 8.25 (d, 1H) 8.00-7.96 (m, 2H) 7.82 (s, 1H) 7.76-7.71 (m, 4H) 7.69-7.66 (m, 2H) 7.60-7.58 (m, 2H) 7.48-7.45 (m, 1H) 2.72 (s, 3 H); MALDI-TOF MS: m / z 556.8, cal. 556.68
[제조예 16] 화합물 137의 제조Preparation Example 16 Preparation of Compound 137
화합물 compound 16-1 16-1 의 제조Manufacturing
피리딘 (450mL)에 4-브로모펜아실 브로마이드(4-bromophenacyl bromide) (45g, 161.9mmol)을 천천히 소분하면서 첨가하였다. 상온에서 1시간 교반한 후, 석출된 고체를 여과하였다. 여과된 고체를 다이에틸 에테르로 세척하여 화합물 16-1 (57g, 수율 98%)을 얻었다.4-bromophenacyl bromide (45 g, 161.9 mmol) was slowly added to pyridine (450 mL) in small portions. After stirring for 1 hour at room temperature, the precipitated solid was filtered. The filtered solid was washed with diethyl ether to give compound 16-1 (57 g, 98% yield).
화합물 compound 16-2 16-2 의 제조Manufacturing
화합물 16-1 (12.5g, 159.4mmol), 트렌스 찰콘(trans-Chalcone) (16.6g, 79.7mmol), 메탄올 (220mL)과 암모늄 아세테이트 (12.3g, 159.4mmol)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 생성된 고체를 여과한 후, 메탄올로 세척하여 화합물 16-2 (12.5g, 수율 40%)을 얻었다.Compound 16-1 (12.5g, 159.4mmol), trans-Chalcone (16.6g, 79.7mmol), methanol (220mL) and ammonium acetate (12.3g, 159.4mmol) were mixed and stirred under reflux for 12 hours. . After the reaction was completed, the mixture was cooled to room temperature, and the resulting solid was filtered and washed with methanol to obtain compound 16-2 (12.5 g, yield 40%).
1H NMR (CDCl3) δ [ppm]: 8.22-8.20 (d, 2H) 8.19-8.10 (d, 2H) 7.93 (d, 1H) 7.88 (d, 1H) 7.77-7.75 (d, 2H) 7.68-7.64 (d, 2H) 7.58-7.51 (m, 4H) 7.50-7.28 (m,2H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.22-8.20 (d, 2H) 8.19-8.10 (d, 2H) 7.93 (d, 1H) 7.88 (d, 1H) 7.77-7.75 (d, 2H) 7.68- 7.64 (d, 2H) 7.58-7.51 (m, 4H) 7.50-7.28 (m, 2H)
화합물 compound 16-3 16-3 의 제조Manufacturing
화합물 16-2 (12.5g, 32.4mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (9.04g, 36mmol), 1,4-다이옥산 (200mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (0.53g, 0.6mmol)과 CH3CO2K (6.35g, 64.7mmol)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 오일 잔사를 에틸아세테이트와 n-헥산으로 컬럼 정제하여 화합물 16-3 (11.8g, 수율 84%)을 얻었다.Compound 16-2 (12.5g, 32.4mmol), Bis (pinacolato) diboron (9.04g, 36mmol), 1,4-dioxane (200mL), 1,1'-bis ( Diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (0.53 g, 0.6 mmol) and CH 3 CO 2 K (6.35 g, 64.7 mmol) were mixed and stirred under reflux for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The oil residue was purified by column purification with ethyl acetate and n-hexane to give compound 16-3 ( 11.8 g, yield 84%).
1H NMR (CDCl3) δ [ppm]: 8.25-8.22 (m, 4H) 7.99-7.97 (d, 2H) 7.95-7.92 (d, 2H) 7.79-7.77 (d, 2H) 7.58-7.47 (m, 6H) 1.41 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.25-8.22 (m, 4H) 7.99-7.97 (d, 2H) 7.95-7.92 (d, 2H) 7.79-7.77 (d, 2H) 7.58-7.47 (m, 6H) 1.41 (s, 12H)
화합물 compound 16-4 16-4 의 제조Manufacturing
화합물 16-3 (11.8g, 27.2mmol), 2,4-다이클로로-6-메틸피리미딘 (4.57g, 28mmol), THF (230mL), Pd(PPh3)4 (0.31g, 0.3 mmol)과 1M K2CO3 수용액 (110mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 오일 잔사를 에틸아세테이트와 n-헥산으로 컬럼 정제하여 화합물 16-4 (9.8g, 수율 83%)을 얻었다.Compound 16-3 (11.8 g, 27.2 mmol), 2,4-dichloro-6-methylpyrimidine (4.57 g, 28 mmol), THF (230 mL), Pd (PPh 3 ) 4 (0.31 g, 0.3 mmol) 1 M K 2 CO 3 aqueous solution (110 mL) was mixed and stirred at reflux for 18 h. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The resulting oil residue was purified by column purification with ethyl acetate and n-hexane to give Compound 16-4 9.8 g, yield 83%) was obtained.
1H NMR (CDCl3) δ [ppm]: 8.38-8.36 (d, 2H) 8.26-8.22 (m, 4H) 7.98-7.96 (d, 2H) 7.79-7.78 (d, 2H) 7.60-7.49 (m, 7H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.38-8.36 (d, 2H) 8.26-8.22 (m, 4H) 7.98-7.96 (d, 2H) 7.79-7.78 (d, 2H) 7.60-7.49 (m, 7H)
화합물 compound 137 137 의 제조Manufacturing
화합물 16-4 (10g, 23mmol), 화합물 5-3 (9.35g, 27.7mmol), THF (200mL), Pd(PPh3)4 (0.27g, 0.23mmol)과 1M K2CO3 수용액 (100mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 석출된 고체를 여과하고, 증류수로 씻어주었다. 얻어진 흰색 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하여 화합물 137 (8.9g, 수율 63%)을 얻었다.Compound 16-4 (10 g, 23 mmol), Compound 5-3 (9.35 g, 27.7 mmol), THF (200 mL), Pd (PPh 3 ) 4 (0.27 g, 0.23 mmol) and 1M K 2 CO 3 aqueous solution (100 mL) The mixture was stirred and refluxed for 18 hours. After the reaction was completed, the mixture was cooled to room temperature, and the precipitated solid was filtered and washed with distilled water. The obtained white solid was suspended while heating with ethyl acetate and filtered to obtain compound 137 (8.9 g, yield 63%).
1H NMR (CDCl3) δ [ppm]: 9.34 (s, 1H) 8.83 (d, 1H) 8.63 (d, 1H) 8.44 (s, 4H) 8.38 (d, 1H) 8.36-8.26 (m, 3H) 8.03 (s, 1H) 7.98 (s, 1H) 7.82 (d, 2H) 7.71 (t, 1H) 7.65 (s, 1H) 7.61-7.48 (m, 7H) 2.76 (s, 3H); LC-MS:m/z 610.4 , cal. 609.74
1 H NMR (CDCl 3 ) δ [ppm]: 9.34 (s, 1 H) 8.83 (d, 1 H) 8.63 (d, 1 H) 8.44 (s, 4 H) 8.38 (d, 1 H) 8.36-8.26 (m, 3 H) 8.03 (s, 1 H) 7.98 (s, 1 H) 7.82 (d, 2 H) 7.71 (t, 1 H) 7.65 (s, 1 H) 7.61-7.48 (m, 7 H) 2.76 (s, 3 H); LC-MS: m / z 610.4, cal. 609.74
[제조예 17] 화합물 127의 제조Preparation Example 17 Preparation of Compound 127
화합물 compound 17-17- 1 One 의of 제조 Produce
THF (250mL), 2,4-다이클로로-6-메틸피리미딘 (25g, 153.4mmol), 1-에티닐벤젠 (16.5g, 161.0mmol), 트리에틸아민 (62.1g, 613.5mmol), Pd(Ph3P)2Cl2 (2.15g, 3.1mmol)와 CuI (0.58g, 3.1mmol)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 증류수를 투입하고, 디클로로메탄으로 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하여 얻어진 고체를 헥산으로 씻어주어 흰색 고체의 화합물 17-1 (25.0g, 71.3%)을 얻었다.THF (250 mL), 2,4-dichloro-6-methylpyrimidine (25 g, 153.4 mmol), 1-ethynylbenzene (16.5 g, 161.0 mmol), triethylamine (62.1 g, 613.5 mmol), Pd ( Ph 3 P) 2 Cl 2 (2.15 g, 3.1 mmol) and CuI (0.58 g, 3.1 mmol) were mixed and stirred under reflux for 12 hours. After the reaction was completed, distilled water was added, the organic layer was extracted with dichloromethane, dried over MgSO 4 , and concentrated under reduced pressure. The obtained solid was washed with hexane to obtain a white solid compound 17-1 (25.0 g, 71.3%).
1H NMR (CDCl3) δ [ppm]: 7.64(d, 2H), 7.45(d, 3H), 7.29(s, 1H), 2.58(s, 3H) 1 H NMR (CDCl 3 ) δ [ppm]: 7.64 (d, 2H), 7.45 (d, 3H), 7.29 (s, 1H), 2.58 (s, 3H)
화합물 compound 17-17- 2 2 의of 제조 Produce
THF/물(80mL:40mL)의 혼합용매에 화합물 17-1 (8g, 34.98mmol), 화합물 5-3 (13.02g, 38.48mmol), Pd(PPh3)4 (0.8g, 0.7mmol)과 K2CO3 (9.7g, 70.0mmol)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 메틸렌 클로라이드(MC)로 유기층을 추출한 후 농축하고, 산성백토 처리한 후 흰색 고체의 화합물 17-2 (8.01g, 수율 56.5%)을 얻었다.Compound 17-1 (8 g, 34.98 mmol), Compound 5-3 (13.02 g, 38.48 mmol), Pd (PPh 3 ) 4 (0.8 g, 0.7 mmol) and K in a mixed solvent of THF / water (80 mL: 40 mL) 2 CO 3 (9.7 g, 70.0 mmol) was mixed and stirred at reflux for 12 hours. After the reaction was completed, the organic layer was extracted with methylene chloride (MC), concentrated, and treated with acidic clay to obtain compound 17-2 (8.01 g, yield 56.5%) as a white solid.
1H NMR (DMSO-d6) δ [ppm]: 9.49(s, 1H), 8.97(d, 2H), 8.66(d, 2H), 7.99(s, 3H), 7.82(m, 4H), 7.64(s, 1H), 2.88(s, 3H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 9.49 (s, 1H), 8.97 (d, 2H), 8.66 (d, 2H), 7.99 (s, 3H), 7.82 (m, 4H), 7.64 (s, 1 H), 2.88 (s, 3 H)
화합물 compound 17-17- 3 3 의of 제조 Produce
1,3-디페닐-2-프로판온 (15g)과 벤질(benzil) (15g)을 에탄올 (105mL)에 녹인 후 수산화칼륨 (2g)을 투입하고 5시간 동안 환류교반하였다. 반응이 완료되면 감압 여과 후 검은색 고체의 화합물 17-3 (24.7g, 수율 89.9%)를 얻었다.1,3-diphenyl-2-propanone (15g) and benzyl (15g) were dissolved in ethanol (105mL), potassium hydroxide (2g) was added thereto, and the mixture was stirred under reflux for 5 hours. After the reaction was completed, a black solid compound 17-3 (24.7 g, yield 89.9%) was obtained after filtration under reduced pressure.
1H NMR (DMSO-d6) δ [ppm]: 7.83(d, 1H), 7.58(d, 1H), 7.43(m, 7H), 7.34(t, 1H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 7.83 (d, 1 H), 7.58 (d, 1 H), 7.43 (m, 7 H), 7.34 (t, 1 H)
화합물 compound 127 127 의of 제조 Produce
화합물 17-2 (14g)과 화합물 17-3 (13.3g)을 디페닐에테르 (70mL)에 녹이고, 4시간동안 환류교반시켰다. 반응이 완료된 후 헥산 (140mL)을 투입하고, 형성된 갈색 고체를 감압여과한 후 실리카겔 컬럼(EA:Hexane = 3:1)으로 분리하여 흰색 고체의 화합물 127 (21g, 수율 79.7%)을 얻었다. Compound 17-2 (14 g) and compound 17-3 (13.3 g) were dissolved in diphenyl ether (70 mL) and stirred under reflux for 4 hours. After the reaction was completed, hexane (140 mL) was added, and the formed brown solid was filtered under reduced pressure, and then separated by a silica gel column (EA: Hexane = 3: 1) to obtain a compound 127 (21 g, yield 79.7%) as a white solid.
1H NMR (CDCl3) δ [ppm]: 8.69(s, 1H), 8.61(d, 1H), 8.34(d, 1H), 8.21(t, 1H), 7.50(m, 2H), 7.28(m, 4H), 7.19(m, 3H), 7.10(m, 2H), 6.92(m, 24H), 6.64(s, 1H); MALDI-TOF MS: m/z 760.42, cal. 760.94
1 H NMR (CDCl 3 ) δ [ppm]: 8.69 (s, 1H), 8.61 (d, 1H), 8.34 (d, 1H), 8.21 (t, 1H), 7.50 (m, 2H), 7.28 (m , 4H), 7.19 (m, 3H), 7.10 (m, 2H), 6.92 (m, 24H), 6.64 (s, 1H); MALDI-TOF MS: m / z 760.42, cal. 760.94
[제조예 18] 화합물 138의 제조Preparation Example 18 Preparation of Compound 138
화합물 compound 18-1 18-1 의 제조Manufacturing
1,3-디페닐-2-프로판온 (10.1g)과 9,10-펜난트렌퀴논(9,10-Phenanthrenequinone) (10g)을 에탄올 (70mL)에 녹인 후 수산화칼륨 (1.35g)을 투입하고 4시간 동안 환류교반하였다. 반응이 완료되면 감압 여과 후 검은색 고체의 화합물 18-1 (10.2g, 수율 55.2%)를 얻었다.Dissolve 1,3-diphenyl-2-propanone (10.1g) and 9,10-Phenanthrenequinone (10g) in ethanol (70mL), add potassium hydroxide (1.35g) It was stirred at reflux for 4 hours. After the reaction was completed, a black solid Compound 18-1 (10.2 g, yield 55.2%) was obtained after filtration under reduced pressure.
1H NMR (DMSO-d6) δ [ppm]: 7.79(d, 1H), 7.59(d, 1H), 7.40(m, 6H), 7.31(t, 1H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 7.79 (d, 1 H), 7.59 (d, 1 H), 7.40 (m, 6 H), 7.31 (t, 1 H)
화합물 compound 138 138 의 제조Manufacturing
화합물 17-2 (10g)과 화합물 18-1 (9.46g)을 디페닐에테르 (50mL)에 녹이고, 4시간동안 환류교반시켰다. 반응이 완료된 후 헥산 (100mL)을 투입하고, 형성된 갈색 고체를 감압여과한 후 실리카겔 컬럼(EA:Hexane = 3:1)으로 분리하여 흰색 고체의 화합물 138 (10.2g, 수율 54.4%)을 얻었다. Compound 17-2 (10 g) and Compound 18-1 (9.46 g) were dissolved in diphenyl ether (50 mL) and stirred under reflux for 4 hours. After completion of the reaction, hexane (100 mL) was added, and the formed brown solid was filtered under reduced pressure, and then separated by a silica gel column (EA: Hexane = 3: 1) to obtain a compound 138 (10.2 g, yield 54.4%) as a white solid.
1H NMR (CDCl3) δ [ppm]: 8.68(s, 1H), 8.62(d, 1H), 8.31(d, 1H), 8.18(t, 1H), 7.50(m, 2H), 7.28(m, 4H), 7.16(m, 3H), 7.08(m, 2H), 6.92(m, 22H), 6.64(s, 1H); MALDI-TOF MS: m/z 758.50, cal. 758.92
1 H NMR (CDCl 3 ) δ [ppm]: 8.68 (s, 1H), 8.62 (d, 1H), 8.31 (d, 1H), 8.18 (t, 1H), 7.50 (m, 2H), 7.28 (m , 4H), 7.16 (m, 3H), 7.08 (m, 2H), 6.92 (m, 22H), 6.64 (s, 1H); MALDI-TOF MS: m / z 758.50, cal. 758.92
[제조예 19] 화합물 132의 제조Preparation Example 19 Preparation of Compound 132
화합물 compound 19-19- 1 One 의of 제조 Produce
1,4-디브로모나프탈렌 (16.7g, 58mmol), 9,9-디메틸-9H-플로우렌-2-일-보론산 (13.9g, 58mmol), THF (300mL), Pd(PPh3)4 (1.34g, 1.16mmol)과 2M K2CO3 수용액 (80mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 메틸렌 클로라이드 (300mL)와 증류수 (300mL)을 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하였다. 농축된 잔사를 SiO2 칼럼 필터하고, 얻어진 여액을 진공농축시킨 후 건조시켜 화합물 19-1 (14.5g, 수율 63%)을 얻었다. 1,4-Dibromonaphthalene (16.7g, 58mmol), 9,9-dimethyl-9H-flowen-2-yl-boronic acid (13.9g, 58mmol), THF (300mL), Pd (PPh 3 ) 4 (1.34 g, 1.16 mmol) and a 2 M K 2 CO 3 aqueous solution (80 mL) were mixed and stirred under reflux for 12 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, methylene chloride (300 mL) and distilled water (300 mL) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The concentrated residue was filtered through a SiO 2 column filter and the filtrate was concentrated in vacuo and dried to give compound 19-1 (14.5 g, yield 63%).
1H NMR (CDCl3) δ [ppm]: 8.42 (d, 1H) 8.05 (d, 1H) 7.92-7.83 (m, 3H) 7.70 (t, 1H) 7.59 (s, 1H) 7.54-7.39 (m, 4H) 7.34-7.29 (m, 3H) 1.60 (s, 6H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.42 (d, 1H) 8.05 (d, 1H) 7.92-7.83 (m, 3H) 7.70 (t, 1H) 7.59 (s, 1H) 7.54-7.39 (m, 4H) 7.34-7.29 (m, 3H) 1.60 (s, 6H)
화합물 compound 19-19- 2 2 의of 제조 Produce
화합물 19-1 (14.5g, 36.3mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (13.8g, 54.4mmol), 1,4-다이옥산 (300mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (1.52g, 2.1mmol)과 CH3CO2K (10.5g, 108mmol)을 혼합하고 6시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 증류수 (300mL)와 에틸아세테이트 (300mL)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 에틸아세테이트에서 재결정하여 화합물 19-2 (14.7g, 수율 93%)을 얻었다. Compound 19-1 (14.5g, 36.3mmol), Bis (pinacolato) diboron (13.8g, 54.4mmol), 1,4-dioxane (300mL), 1,1'-bis (Diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1.52 g, 2.1 mmol) and CH 3 CO 2 K (10.5 g, 108 mmol) were mixed and refluxed for 6 hours. After the reaction was completed, the mixture was cooled to room temperature, distilled water (300 mL) and ethyl acetate (300 mL) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated carbon and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized from ethyl acetate to obtain compound 19-2 (14.7 g, yield 93%).
1H NMR (CDCl3) δ [ppm]: 8.91 (d, 1H) 8.19 (d, 1H) 8.11 (d, 1H) 7.87 (dd, 2H) 7.60-7.56 (m, 2H) 7.53-7.44 (m, 4H) 7.42-7.35 (m, 2H) 1.57 (s, 6H) 1.48 (s, 12H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.91 (d, 1H) 8.19 (d, 1H) 8.11 (d, 1H) 7.87 (dd, 2H) 7.60-7.56 (m, 2H) 7.53-7.44 (m, 4H) 7.42-7.35 (m, 2H) 1.57 (s, 6H) 1.48 (s, 12H)
화합물 compound 19-19- 3 3 의of 제조 Produce
화합물 19-2 (14.7g, 33.3mmol), 2,6-디클로로-4-메틸피리미딘 (6.4g, 40mmol), THF (300mL), Pd(PPh3)4 (0.9g, 0.78mmol)와 2M K2CO3 수용액 (80mL)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 메틸렌 클로라이드 (300mL)와 증류수 (300mL)을 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하였다. 농축된 잔사를 SiO2 칼럼 필터하고, 얻어진 여액을 진공농축시킨 후 건조시켜 화합물 19-3 (10.4g, 수율 70%)을 얻었다. Compound 19-2 (14.7g, 33.3mmol), 2,6-dichloro-4-methylpyrimidine (6.4g, 40mmol), THF (300mL), Pd (PPh 3 ) 4 (0.9g, 0.78mmol) and 2M Aqueous K 2 CO 3 aqueous solution (80 mL) was mixed and stirred at reflux for 12 h. After the reaction was completed, the reaction mixture was cooled to room temperature, methylene chloride (300 mL) and distilled water (300 mL) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The concentrated residue was filtered through a SiO 2 column filter, the filtrate was concentrated in vacuo and dried to give compound 19-3 (10.4 g, yield 70%).
1H NMR (CDCl3) δ [ppm]: 8.50 (d, 1H) 8.44 (s, 1H) 8.15 (t, 2H) 8.11-8.076 (m, 4H) 8.042 (s, 1H) 7.98-7.92 (t, 1H) 7.92 (d, 1H) 7.81-7.77 (m, 2H) 7.77-7.64 (m, 6H) 7.45 (d, 1H) 7.41-7.37 (m, 2H) 2.07 (s, 1H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.50 (d, 1H) 8.44 (s, 1H) 8.15 (t, 2H) 8.11-8.076 (m, 4H) 8.042 (s, 1H) 7.98-7.92 (t, 1H) 7.92 (d, 1H) 7.81-7.77 (m, 2H) 7.77-7.64 (m, 6H) 7.45 (d, 1H) 7.41-7.37 (m, 2H) 2.07 (s, 1H)
화합물 compound 132 132 의of 제조 Produce
화합물 19-3 (14.4g, 23.3mmol), 화합물 5-3 (8.7g, 25.7mmol), THF (300mL), Pd(PPh3)4 (0.54g, 0.47mmol)와 2M K2CO3 수용액 (50mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 메틸렌 클로라이드 (300mL)와 증류수 (300mL)을 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하였다. 얻어진 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하고 에틸아세테이트로 세척하여 화합물 132 (5.7g, 수율 39%)을 얻었다.Compound 19-3 (14.4 g, 23.3 mmol), Compound 5-3 (8.7 g, 25.7 mmol), THF (300 mL), Pd (PPh 3 ) 4 (0.54 g, 0.47 mmol) and 2M K 2 CO 3 aqueous solution ( 50 mL) was stirred and refluxed for 18 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, methylene chloride (300 mL) and distilled water (300 mL) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The obtained solid was suspended with ethyl acetate, filtered and washed with ethyl acetate to give compound 132 (5.7 g, yield 39%).
1H NMR (CDCl3) δ [ppm]: 9.18 (t, 1H), 8.80 (d, 1H), 8.77 (s, 1H), 8.61 (d, 1H), 8.45 (d, 1H), 8.34 (d, 1H), 8.32-8.21 (m, 2H), 8.17 (d, 1H), 8.10 (s, 1H), 8.08 (m, 3H), 7.98 (m, 2H), 7.95 (s, 1H), 7.89-7.82 (m, 2H) 7.77 (d, 1H) 7.71-7.65 (m, 5H) 7.53(d, 1H) 7.48-7.45 (t, 1H) 7.43 (d, 1H) 7.41-7.38 (m, 2H) 2.38 (s, 1H); MALDI-TOF MS: m/z 717.2 cal. 718.87
1 H NMR (CDCl 3 ) δ [ppm]: 9.18 (t, 1H), 8.80 (d, 1H), 8.77 (s, 1H), 8.61 (d, 1H), 8.45 (d, 1H), 8.34 (d , 1H), 8.32-8.21 (m, 2H), 8.17 (d, 1H), 8.10 (s, 1H), 8.08 (m, 3H), 7.98 (m, 2H), 7.95 (s, 1H), 7.89- 7.82 (m, 2H) 7.77 (d, 1H) 7.71-7.65 (m, 5H) 7.53 (d, 1H) 7.48-7.45 (t, 1H) 7.43 (d, 1H) 7.41-7.38 (m, 2H) 2.38 ( s, 1 H); MALDI-TOF MS: m / z 717.2 cal. 718.87
[제조예 20] 화합물 135의 제조Preparation Example 20 Preparation of Compound 135
화합물 compound 20-1 20-1 의 제조Manufacturing
4,4’-디브로모바이페닐 (30g, 96mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (66g, 260mmol), 1,4-다이옥산 (600mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (4.08g, 5.6mmol)과 CH3CO2K (28.3 g, 288 mmol)을 혼합하고 6시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 에틸아세테이트에서 재결정하여 화합물 20-1 (25g, 수율 76%)을 얻었다. 4,4'-dibromobiphenyl (30g, 96mmol), bis (pinacolato) diboron (66g, 260mmol), 1,4-dioxane (600mL), 1,1'- Bis (diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (4.08 g, 5.6 mmol) and CH 3 CO 2 K (28.3 g, 288 mmol) were mixed and refluxed for 6 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized from ethyl acetate to obtain compound 20-1 (25 g, yield 76%).
1H NMR (CDCl3) δ [ppm]: 7.91 (d, 4H) 7.66 (d, 4H) 1.39 (s, 24H) 1 H NMR (CDCl 3 ) δ [ppm]: 7.91 (d, 4H) 7.66 (d, 4H) 1.39 (s, 24H)
화합물 compound 20-2 20-2 의 제조Manufacturing
화합물 20-1 (27.1g, 66.7mmol), 2,6-디클로로-4-메틸피리미딘 (23.92g, 146mmol), THF (500mL), Pd(PPh3)4 (3.1g, 2.7mmol), 2M K2CO3 수용액 (150mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 메틸렌 클로라이드 (500mL)와 증류수 (500mL)을 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하였다. 농축된 잔사를 SiO2 칼럼 필터하고, 얻어진 여액을 감압 농축시킨 후 건조시켜 화합물 20-2 (9.36g, 수율 68%)을 얻었다. Compound 20-1 (27.1 g, 66.7 mmol), 2,6-dichloro-4-methylpyrimidine (23.92 g, 146 mmol), THF (500 mL), Pd (PPh 3 ) 4 (3.1 g, 2.7 mmol), 2M Aqueous K 2 CO 3 solution (150 mL) was mixed and stirred at reflux for 12 h. After the reaction was completed, the mixture was cooled to room temperature, methylene chloride (500 mL) and distilled water (500 mL) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The concentrated residue was filtered through a SiO 2 column filter, and the filtrate was concentrated under reduced pressure and dried to obtain compound 20-2 (9.36 g, yield 68%).
1H NMR (CDCl3) δ [ppm]: 8.23(t, 2H) 7.82 (d, 2H) 7.77 (d, 2H) 7.74 (d, 2H) 7.58 (s, 2H) 2.65 (s, 6H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.23 (t, 2H) 7.82 (d, 2H) 7.77 (d, 2H) 7.74 (d, 2H) 7.58 (s, 2H) 2.65 (s, 6H)
화합물 compound 135 135 의 제조Manufacturing
화합물 20-2 (9.36g, 23.3mmol), 화합물 5-3 (16.3g, 48.3mmol), THF (300mL), Pd(PPh3)4 (0.53g, 0.46mmol)과 2M K2CO3 수용액 (80mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 메틸렌 클로라이드 (300mL)와 증류수 (300mL)을 가하여 유기층을 추출하고 MgSO4로 건조한 후 감압 농축하였다. 얻어진 고체를 에틸아세테이트로 가열하면서 현탁시킨 후 여과하고 에틸아세테이트로 세척하여 화합물 135 (13g, 수율 74%)을 얻었다.Compound 20-2 (9.36 g, 23.3 mmol), Compound 5-3 (16.3 g, 48.3 mmol), THF (300 mL), Pd (PPh 3 ) 4 (0.53 g, 0.46 mmol) and 2M K 2 CO 3 aqueous solution ( 80 mL) was stirred and refluxed for 18 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, methylene chloride (300 mL) and distilled water (300 mL) were added, the organic layer was extracted, dried over MgSO 4 , and concentrated under reduced pressure. The obtained solid was suspended with ethyl acetate, filtered and washed with ethyl acetate to give compound 135 (13 g, yield 74%).
1H NMR (CDCl3) δ [ppm]: 8.77(d, 2H) 8.62 (d, 2H) 8.45 (d, 2H) 8.39 (d, 2H) 8.24 (m, 2H) 8.14 (d, 2H) 7.89 (m, 6H) 7.70 (t, 2H) 7.60 (s, 2H) 7.51 (d, 2H) 2.65 (s, 6H)
1 H NMR (CDCl 3 ) δ [ppm]: 8.77 (d, 2H) 8.62 (d, 2H) 8.45 (d, 2H) 8.39 (d, 2H) 8.24 (m, 2H) 8.14 (d, 2H) 7.89 ( m, 6H) 7.70 (t, 2H) 7.60 (s, 2H) 7.51 (d, 2H) 2.65 (s, 6H)
[제조예 21] 화합물 139의 제조Preparation Example 21 Preparation of Compound 139
화합물 compound 21-21- 1 One 의of 제조 Produce
2,4,6-트리클로로피리미딘 (33.5g, 182.6mmol), 화합물 15-1 (55.56g, 182.6mmol), THF (503mL), Pd(PPh3)4 (2.12g, 1.83mmol)과 1M K2CO3 수용액 (252mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 아세톤에 완전히 용해시킨 후 재결정하여 화합물 21-1 (36g, 수율 61%)을 얻었다.2,4,6-trichloropyrimidine (33.5 g, 182.6 mmol), compound 15-1 (55.56 g, 182.6 mmol), THF (503 mL), Pd (PPh 3 ) 4 (2.12 g, 1.83 mmol) and 1M K 2 CO 3 Aqueous solutions (252 mL) were mixed and stirred at reflux for 18 h. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was completely dissolved in acetone, followed by recrystallization to obtain compound 21-1 (36 g, yield 61%).
1H NMR (CDCl3) δ [ppm]: 8.82-8.80 (d, 1H), 8.75-8.73 (d, 1H)114 (d, 1H), 8.00 (s, 1H), 7.98 (s, 1H), 7.81-7.67 (m, 5H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.82-8.80 (d, 1H), 8.75-8.73 (d, 1H) 114 (d, 1H), 8.00 (s, 1H), 7.98 (s, 1H), 7.81-7.67 (m, 5H)
화합물 compound 21-21- 2 2 의of 제조 Produce
화합물 21-1 (29.6g, 91.0mmol), 피리딘-3-일-3-보론산 (11.19g, 91.0mmol), THF (592mL), Pd(PPh3)4 (1.06g, 0.91mmol)과 2M K2CO3 수용액 (296mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 재결정하여 화합물 21-2 (15.36g, 수율 47%)을 얻었다.Compound 21-1 (29.6g, 91.0mmol), pyridin-3-yl-3-boronic acid (11.19g, 91.0mmol), THF (592mL), Pd (PPh 3 ) 4 (1.06g, 0.91mmol) and 2M Aqueous K 2 CO 3 solution (296 mL) was mixed and stirred at reflux for 18 h. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized to obtain compound 21-2 (15.36 g, yield 47%).
1H NMR (DMSO-d6) δ [ppm]: 9.36-9.35 (d, 1H) 8.84-8.81 (d, 2H) 8.77-8.75 (d, 1H) 8.55-8.52 (m, 1H) 8.20-8.18 (d, 1H) 8.05 (d, 2H) 8.01-7.99 (d, 1H) 7.80-7.76 (m, 2H) 7.71-7.65 (m, 2H) 7.54-7.50 (q, 1H) 1 H NMR (DMSO-d 6 ) δ [ppm]: 9.36-9.35 (d, 1H) 8.84-8.81 (d, 2H) 8.77-8.75 (d, 1H) 8.55-8.52 (m, 1H) 8.20-8.18 ( d, 1H) 8.05 (d, 2H) 8.01-7.99 (d, 1H) 7.80-7.76 (m, 2H) 7.71-7.65 (m, 2H) 7.54-7.50 (q, 1H)
화합물 compound 139139 의 제조Manufacturing
화합물 21-2 (14g, 38.1mmol), 화합물 5-3 (22g, 65.0mmol), THF (400mL), Pd(PPh3)4 (0.7g, 0.6 mmol)과 2M K2CO3 수용액 (200mL)을 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 디클로로메탄을 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 재결정하여 화합물 139 (9g, 수율 45%)을 얻었다.Compound 21-2 (14 g, 38.1 mmol), Compound 5-3 (22 g, 65.0 mmol), THF (400 mL), Pd (PPh 3 ) 4 (0.7 g, 0.6 mmol) and 2M K 2 CO 3 aqueous solution (200 mL) The mixture was stirred and refluxed for 18 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, saturated aqueous NaCl solution and dichloromethane were added, the organic layer was extracted, dried over MgSO 4 , treated with activated carbon, and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized to obtain compound 139 (9 g, yield 45%).
1H NMR (DMSO-d6) δ [ppm]: 9.57 (d, 1H) 9.42-9.41 (t, 2H) 8.91-8.80 (m, 4H) 8.72-8.69 (m, 1H) 8.62-8.61 (m, 1H) 8.42-8.32 (m, 3H) 8.14 (s, 1H) 8.09 (s, 1H)8.06-8.04 (d, 1H) 7.82-7.68 (m, 5H) 7.60-7.57 (m, 1H) 7.50-7.47 (m, 1H); LC-MS:m/z 544.4, cal. 543.64
1 H NMR (DMSO-d 6 ) δ [ppm]: 9.57 (d, 1H) 9.42-9.41 (t, 2H) 8.91-8.80 (m, 4H) 8.72-8.69 (m, 1H) 8.62-8.61 (m, 1H) 8.42-8.32 (m, 3H) 8.14 (s, 1H) 8.09 (s, 1H) 8.06-8.04 (d, 1H) 7.82-7.68 (m, 5H) 7.60-7.57 (m, 1H) 7.50-7.47 ( m, 1 H); LC-MS: m / z 544.4, cal. 543.64
[제조예 22] 화합물 128의 제조Preparation Example 22 Preparation of Compound 128
화합물 compound 22-1 22-1 의 제조Manufacturing
화합물 15-1 (31.8g, 104.5mmol), 2,4-디클로로-6-메틸피리미딘 (17.3g, 106.1mmol), THF (636mL), Pd(PPh3)4 (2.46g, 2.1mmol)과 2M K2CO3 수용액 (318mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 아세톤에 완전히 용해시킨 후 재결정하여 화합물 22-1 (9.8g, 수율 31%)을 얻었다.Compound 15-1 (31.8 g, 104.5 mmol), 2,4-dichloro-6-methylpyrimidine (17.3 g, 106.1 mmol), THF (636 mL), Pd (PPh 3 ) 4 (2.46 g, 2.1 mmol) Aqueous 2M K 2 CO 3 solution (318 mL) was mixed and stirred at reflux for 18 h. After the reaction was completed, the reaction mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate were added, the organic layer was extracted, dried over MgSO 4 , treated with activated carbon, and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was completely dissolved in acetone, and then recrystallized to obtain compound 22-1 (9.8 g, yield 31%).
1H NMR (CDCl3) δ [ppm]: 8.98-8.96 (d, 1H), 8.93-8.91 (d, 1H), 8.15-8.10 (m, 3H), 7.87 (s, 1H), 7.83-7.67 (m, 4H) 1 H NMR (CDCl 3 ) δ [ppm]: 8.98-8.96 (d, 1H), 8.93-8.91 (d, 1H), 8.15-8.10 (m, 3H), 7.87 (s, 1H), 7.83-7.67 ( m, 4H)
화합물 compound 128128 의 제조Manufacturing
화합물 22-1 (9.8g, 32.2mmol), 화합물 5-3 (10.88g, 32.2mmol), THF (196mL), Pd(PPh3)4 (0.75g, 0.64 mmol)과 1M K2CO3 수용액 (98mL)를 혼합하고 18시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 얻어진 고체를 재결정하여 화합물 128 (11g, 수율 71%)을 얻었다.Compound 22-1 (9.8 g, 32.2 mmol), Compound 5-3 (10.88 g, 32.2 mmol), THF (196 mL), Pd (PPh 3 ) 4 (0.75 g, 0.64 mmol) and 1M aqueous solution of K 2 CO 3 ( 98 mL) was stirred and refluxed for 18 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate were added, the organic layer was extracted, dried over MgSO 4 , treated with activated carbon, and filtered through Celite. The obtained filtrate was concentrated under reduced pressure, and the obtained solid was recrystallized to obtain compound 128 (11 g, yield 71%).
1H NMR (DMSO-d6) δ [ppm]: 9.22 (s, 1H) 9.02-9.00 (d, 1H) 8.96-8.94 (d, 1H) 8.70-8.68 (d, 1H) 8.65-8.64 (d, 1H) 8.51-8.49 (d, 1H) 8.29-8.27 (m, 2H) 8.18-8.14 (m, 1H) 7.84-7.61 (m, 8H) 7.40-7.37 (m, 1H) LC-MS:m/z 480.99, cal. 480.58
1 H NMR (DMSO-d 6 ) δ [ppm]: 9.22 (s, 1H) 9.02-9.00 (d, 1H) 8.96-8.94 (d, 1H) 8.70-8.68 (d, 1H) 8.65-8.64 (d, 1H) 8.51-8.49 (d, 1H) 8.29-8.27 (m, 2H) 8.18-8.14 (m, 1H) 7.84-7.61 (m, 8H) 7.40-7.37 (m, 1H) LC-MS: m / z 480.99 , cal. 480.58
[제조예 23] 화합물 134의 제조Preparation Example 23 Preparation of Compound 134
화합물 compound 23-23- 1 One 의of 제조 Produce
CuBr2 (50g, 223.8mmol), Al2O3 (100g, 980.8mmol)와 물 (200mL)을 혼합하고, 20분간 교반하였다. 교반이 완료되면 상기 반응물을 농축하여 건조한 결정 (100g)을 250mL-3구 둥근바닥플라스크에 넣고, 1-브로모나프탈렌 (25g, 120.7mmol)과 클로로벤젠 (100mL)를 가하고 2시간동안 환류교반하였다. 반응이 완료되면 여과하고 감압농축하였다. 농축된 잔사를 메탄올 (200mL)에 적가하여 냉동실에 24시간동안 방치하여 얻어진 결정을 여과하여 화합물 23-1 (20.7g)을 얻었다.CuBr 2 (50 g, 223.8 mmol), Al 2 O 3 (100 g, 980.8 mmol) and water (200 mL) were mixed and stirred for 20 minutes. After stirring was complete, the reaction mixture was concentrated and dried crystals (100 g) were placed in a 250 mL three-neck round bottom flask, 1-bromonaphthalene (25 g, 120.7 mmol) and chlorobenzene (100 mL) were added, and the mixture was stirred under reflux for 2 hours. . After the reaction was completed, the mixture was filtered and concentrated under reduced pressure. The concentrated residue was added dropwise to methanol (200 mL), and the crystals obtained by standing in a freezer for 24 hours were filtered to obtain compound 23-1 (20.7 g).
화합물 compound 23-23- 2 2 의of 제조 Produce
화합물 23-1 (20.7g, 72.4mmol), 1-나프탈렌보론산 (12.45g, 72.4mmol), Pd(PPh3)4 (0.84g, 0.7mmol), 1M K2CO3 수용액 (200mL)와 THF (410mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 화합물 23-2 (14.79g, 42.8mmol)을 얻었다.Compound 23-1 (20.7g, 72.4mmol), 1-naphthaleneboronic acid (12.45g, 72.4mmol), Pd (PPh 3 ) 4 (0.84g, 0.7mmol), 1M K 2 CO 3 aqueous solution (200mL) and THF (410 mL) was mixed and stirred at reflux for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The resulting filtrate was concentrated under reduced pressure to give compound 23-2 (14.79 g, 42.8 mmol).
화합물 compound 23-323-3 의 제조Manufacturing
화합물 23-2 (14.79g, 44.4mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (12.4g, 49mmol), 1,4-다이옥산 (375mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (0.72g, 0.9mmol)과 CH3CO2K (8.71g, 88.8mmol)를 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 오일 상의 화합물 23-3 (16.88g)을 얻었다.Compound 23-2 (14.79 g, 44.4 mmol), bis (pinacolato) diboron (12.4 g, 49 mmol), 1,4-dioxane (375 mL), 1,1'-bis ( Diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (0.72 g, 0.9 mmol) and CH 3 CO 2 K (8.71 g, 88.8 mmol) were mixed and stirred under reflux for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The resulting filtrate was concentrated under reduced pressure to give compound 23-3 (16.88 g) in an oil phase.
화합물 compound 23-423-4 의 제조Manufacturing
2,4-다이클로로-6-메틸피리미딘 (7.24g, 44.4mmol), 화합물 23-3 (16.88g, 44.4mmol), THF (340mL), Pd(PPh3)4 (0.84g, 0.7mmol)와 1M K2CO3 수용액 (207mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 오일 상의 화합물 23-4 (16.91g)을 얻었다.2,4-dichloro-6-methylpyrimidine (7.24 g, 44.4 mmol), compound 23-3 (16.88 g, 44.4 mmol), THF (340 mL), Pd (PPh 3 ) 4 (0.84 g, 0.7 mmol) And 1M K 2 CO 3 aqueous solution (207 mL) were mixed and stirred under reflux for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The resulting filtrate was concentrated under reduced pressure to give compound 23-4 (16.91 g) in an oil phase.
화합물 compound 134134 의 제조Manufacturing
화합물 23-4 (16.91g, 44.4mmol), 화합물 5-3 (15.02g, 44.4mmol), THF (340mL), Pd(PPh3)4 (0.51g, 0.4mmol)와 1M K2CO3 수용액 (170mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 반응물을 여과하여 얻어진 흰색 고체를 에틸아세테이트로 가열하면서 현탁교반시킨 후 여과하여 화합물 134 (15.4g, 수율 62.5%)을 얻었다.Compound 23-4 (16.91g, 44.4mmol), Compound 5-3 (15.02g, 44.4mmol), THF (340mL), Pd (PPh 3 ) 4 (0.51g, 0.4mmol) and 1M K 2 CO 3 aqueous solution ( 170 mL) was stirred and refluxed for 12 h. After the reaction was completed, the reaction mixture was cooled to room temperature and the reaction product was filtered. The white solid was suspended and stirred while heating with ethyl acetate, and then filtered to obtain Compound 134 (15.4 g, 62.5% yield).
1H NMR (CDCl3) δ [ppm]: 7.48 (s, 1H) 8.25 (s, 1H) 8.46 (d, 1H) 8.71 (d, 1H) 8.34 (d, 1H) 8.26 (d, 1H) 8.05 (d, 2H) 7.65 (t, 1H) 7.52 (t, 2H) 7.21-7.39 (m, 9H) 7.28 (s, 1H) 7.24 (d, 2H) 7.51 (s, 1H) 2.69 (s, 3H) LC-MS:m/z 558.60, cal. 558.69
1 H NMR (CDCl 3 ) δ [ppm]: 7.48 (s, 1 H) 8.25 (s, 1 H) 8.46 (d, 1 H) 8.71 (d, 1 H) 8.34 (d, 1 H) 8.26 (d, 1 H) 8.05 ( d, 2H) 7.65 (t, 1H) 7.52 (t, 2H) 7.21-7.39 (m, 9H) 7.28 (s, 1H) 7.24 (d, 2H) 7.51 (s, 1H) 2.69 (s, 3H) LC- MS: m / z 558.60, cal. 558.69
[제조예 24] 화합물 136의 제조Preparation Example 24 Preparation of Compound 136
화합물 compound 24-1 24-1 의 제조Manufacturing
2-(4-브로모페닐)-1,1-다이페닐에틸렌 (25g, 74.6mmol), 비스(피나콜라토)디보론(Bis(pinacolato)diboron) (20.83g, 82mmol), 1,4-다이옥산 (375mL), 1,1'-비스(디페닐포스피노)페로센-팔라듐(II)디클로라이드 디클로로메탄 착물 (1.22g, 1.5mmol)과 CH3CO2K (14.64g, 149.1mmol)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 얻어진 여액을 감압 농축하여 오일 상의 화합물 24-1 (28.5g)을 얻었다.2- (4-bromophenyl) -1,1-diphenylethylene (25g, 74.6mmol), bis (pinacolato) diboron (20.83g, 82mmol), 1,4- Dioxane (375 mL), 1,1'-bis (diphenylphosphino) ferrocene-palladium (II) dichloride dichloromethane complex (1.22 g, 1.5 mmol) and CH 3 CO 2 K (14.64 g, 149.1 mmol) The mixture was refluxed for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. The obtained filtrate was concentrated under reduced pressure to give compound 24-1 (28.5 g) in an oil phase.
화합물 compound 24-2 24-2 의 제조Manufacturing
2,4-다이클로로-6-메틸피리미딘 (12.16g, 74.6mmol), 화합물 24-1 (28.5g, 74.5mmol), THF (570mL), Pd(PPh3)4 (0.86g, 0.7 mmol)과 1M K2CO3 수용액 (285mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 포화 NaCl수용액과 에틸아세테이트(EA)를 가하여 유기층을 추출하고 MgSO4로 건조한 후 활성탄처리하고, 셀라이트 여과하였다. 감압 농축한다. 얻어진 여액을 감압 농축하여 오일 상의 화합물 24-2 (28.55g)을 얻었다.2,4-Dichloro-6-methylpyrimidine (12.16 g, 74.6 mmol), compound 24-1 (28.5 g, 74.5 mmol), THF (570 mL), Pd (PPh 3 ) 4 (0.86 g, 0.7 mmol) And 1M K 2 CO 3 aqueous solution (285 mL) were mixed and stirred under reflux for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, saturated aqueous NaCl solution and ethyl acetate (EA) were added, the organic layer was extracted, dried over MgSO 4 , and treated with activated charcoal and filtered through Celite. Concentrate under reduced pressure. The resulting filtrate was concentrated under reduced pressure to give compound 24-2 (28.55 g) in an oil phase.
화합물 compound 136136 의 제조Manufacturing
화합물 24-2 (28.55g, 74.6mmol), 화합물 5-3 (25.22g, 74.6mmol), THF (570mL), Pd(PPh3)4 (0.86g, 0.7mmol)과 1M K2CO3 수용액 (286mL)을 혼합하고 12시간동안 환류교반하였다. 반응이 완료되면 상온으로 냉각하고 반응물을 여과하여 얻어진 흰색 고체를 에틸아세테이트로 가열하면서 현탁교반시킨 후 여과하여 화합물 136 (30.6g, 수율 73.45%)을 얻었다.Compound 24-2 (28.55g, 74.6mmol), Compound 5-3 (25.22g, 74.6mmol), THF (570mL), Pd (PPh 3 ) 4 (0.86g, 0.7mmol) and 1M K 2 CO 3 aqueous solution ( 286 mL) were stirred and refluxed for 12 h. After the reaction was completed, the reaction mixture was cooled to room temperature and the reaction product was filtered. The white solid was suspended and stirred while heating with ethyl acetate, and then filtered to obtain Compound 136 (30.6 g, yield 73.45%).
1H NMR (CDCl3) δ [ppm]: 7.28 (s, 1H) 9.25 (s, 1H) 8.74 (d, 1H) 8.61 (d, 1H) 8.34 (d, 1H) 8.26 (d, 1H) 8.05 (d, 2H) 7.65 (t, 1H) 7.50 (t, 2H) 7.41-7.33 (m, 9H) 7.28 (s, 1H) 7.23 (d, 2H) 7.21 (s, 1H) 2.68 (s, 3H); LC-MS:m/z 558.60, cal. 558.69
1 H NMR (CDCl 3 ) δ [ppm]: 7.28 (s, 1 H) 9.25 (s, 1 H) 8.74 (d, 1 H) 8.61 (d, 1 H) 8.34 (d, 1 H) 8.26 (d, 1 H) 8.05 ( d, 2H) 7.65 (t, 1H) 7.50 (t, 2H) 7.41-7.33 (m, 9H) 7.28 (s, 1H) 7.23 (d, 2H) 7.21 (s, 1H) 2.68 (s, 3H); LC-MS: m / z 558.60, cal. 558.69
[실시예 1] 본 발명에 따른 화합물 1을 이용한 유기 발광 소자의 제작Example 1 Fabrication of Organic Light-Emitting Device Using Compound 1 According to the Present Invention
박막 두께가 150 nm인 ITO(인듐 주석 산화물) 투명 전극 라인을 갖는, 40 mm × 40 mm × 0.7 mm 크기의 유리기판을 세제가 용해된 증류수 속에서 10분 동안 초음파로 세정하고, 증류수에서 10분 동안 2 회 반복 세정하였다. 증류수 세정이 끝나면 이소프로필알코올, 아세톤, 메탄올의 용제를 사용하여 기판을 순차적으로 10분씩 초음파세척하고 건조시켰다. 이어, 산소/아르곤 플라즈마를 이용하여 건식세정한 후, 투명 전극 라인을 갖는 유리 기판을 진공 증착 장치의 기판 홀더에 장착하고 투명 전극 라인이 형성되어 있는 면상에, 상기 투명 전극을 덮도록 막 두께 60 nm의 IDE-406(하기 구조, I사)막을 정공 주입층으로서 성막하였다. 다음에, IDE-406 막상에 막 두께 30 nm의 4,4'-비스[N-(1-나프틸)-N-페닐아미노]바이페닐 막(이하, α-NPB 막)을 정공 수송층으로서 성막하였다. 다음에, NPB 막상에 도판트로서 하기 구조의 BD-1을, 발광호스트로서 β-ADN(9,10-디(나프탈렌-2-일)안트라센)에 5%의 중량비로 증착하여 막 두께 20 nm의 발광층으로서 성막하였다. A 40 mm × 40 mm × 0.7 mm sized glass substrate with an ITO (indium tin oxide) transparent electrode line with a thickness of 150 nm was ultrasonically cleaned in distilled water with detergent for 10 minutes and 10 minutes in distilled water. The wash was repeated twice. After the distilled water was washed, the substrate was sequentially ultrasonically cleaned for 10 minutes and dried using a solvent of isopropyl alcohol, acetone and methanol. Subsequently, after dry cleaning using oxygen / argon plasma, the glass substrate having the transparent electrode lines was mounted on the substrate holder of the vacuum deposition apparatus, and the film thickness 60 was formed so as to cover the transparent electrodes on the surface where the transparent electrode lines were formed. A nm IDE-406 (following structure, I company) film was formed as a hole injection layer. Next, a 4,4'-bis [N- (1-naphthyl) -N-phenylamino] biphenyl film (hereinafter, α-NPB film) having a thickness of 30 nm was formed on the IDE-406 film as a hole transporting layer. It was. Next, BD-1 having the following structure as a dopant was deposited on the NPB film in β-ADN (9,10-di (naphthalen-2-yl) anthracene) as a light emitting host at a weight ratio of 5%, and the film thickness was 20 nm. It formed into a film as a light emitting layer of.
상기 발광층 상에 본 발명의 화합물 1을 증착시켜 막 두께 20 nm의 전자 수송층으로 성막하였다. 이어, 그 위에 LiF을 증착시켜 전자 주입층을 형성하였다. 이 LiF 막상에 금속 알루미늄을 증착시켜 금속 음극을 형성하여 유기 발광 소자를 제작하였다.
Compound 1 of the present invention was deposited on the light emitting layer to form a film with an electron transporting layer having a thickness of 20 nm. Subsequently, LiF was deposited thereon to form an electron injection layer. Metal aluminum was deposited on the LiF film to form a metal cathode to fabricate an organic light emitting device.
[실시예 2] 본 발명에 따른 화합물 2을 이용한 유기 발광 소자의 제작Example 2 Fabrication of Organic Light-Emitting
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 2를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that
[실시예 3] 본 발명에 따른 화합물 3을 이용한 유기 발광 소자의 제작Example 3 Fabrication of Organic Light-Emitting
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 3를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that
[실시예 4] 본 발명에 따른 화합물 4을 이용한 유기 발광 소자의 제작Example 4 Fabrication of Organic Light-Emitting Device Using Compound 4 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 4를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 4 was used instead of Compound 1 as an electron transporting layer material in Example 1.
[실시예 5] 본 발명에 따른 화합물 5을 이용한 유기 발광 소자의 제작Example 5 Fabrication of Organic Light-Emitting Device Using Compound 5 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 5를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 5 was used instead of Compound 1 as the electron transport layer material in Example 1.
[실시예 6] 본 발명에 따른 화합물 6을 이용한 유기 발광 소자의 제작Example 6 Fabrication of Organic Light-Emitting
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 6를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that
[실시예 7] 본 발명에 따른 화합물 7을 이용한 유기 발광 소자의 제작Example 7 Fabrication of Organic Light-Emitting
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 7를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that
[실시예 8] 본 발명에 따른 화합물 8을 이용한 유기 발광 소자의 제작Example 8 Fabrication of Organic Light-Emitting
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 8를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that
[실시예 9] 본 발명에 따른 화합물 9을 이용한 유기 발광 소자의 제작Example 9 Fabrication of Organic Light-Emitting Device Using Compound 9 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 9를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 9 was used instead of Compound 1 as an electron transporting layer material in Example 1.
[실시예 10] 본 발명에 따른 화합물 10을 이용한 유기 발광 소자의 제작Example 10 Fabrication of Organic Light-Emitting Device Using Compound 10 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 10를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 10 was used instead of Compound 1 as an electron transporting layer material in Example 1.
[실시예 11] 본 발명에 따른 화합물 11을 이용한 유기 발광 소자의 제작Example 11 Fabrication of Organic Light-Emitting Device Using Compound 11 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 11를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 11 was used instead of Compound 1 as an electron transporting layer material in Example 1.
[실시예 12] 본 발명에 따른 화합물 12을 이용한 유기 발광 소자의 제작Example 12 Fabrication of Organic Light-Emitting Device Using Compound 12 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 12를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 12 was used instead of Compound 1 as an electron transporting layer material in Example 1.
[실시예 13] 본 발명에 따른 화합물 13을 이용한 유기 발광 소자의 제작Example 13 Fabrication of Organic Light-Emitting Device Using Compound 13 According to the Present Invention
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 화합물 13를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound 13 was used instead of Compound 1 as an electron transporting material in Example 1.
[비교예 1] 화합물 ETM-1을 이용한 유기 발광 소자의 제작Comparative Example 1 Fabrication of Organic Light - Emitting Device Using Compound ETM-1
상기 실시예 1에서 전자 수송층 재료로서 화합물 1 대신에 하기 구조의 화합물 ETM-1를 사용하는 것을 제외하고는 실시예 1과 동일한 공정 하에서 유기 발광 소자를 제작하였다.An organic light-emitting device was manufactured in the same manner as in Example 1, except that Compound ETM-1 having the following structure was used instead of Compound 1 as an electron transporting layer material in Example 1.
상기 실시예 1 내지 13 및 비교예 1에서 제작된 유기 발광 소자의 전기 발광 특성 및 기초 물성 측정 결과를 하기 표 1에 나타내었다.Table 1 shows the electroluminescent properties and basic physical property measurement results of the organic light emitting diodes manufactured in Examples 1 to 13 and Comparative Example 1.
((
mAmA
/Of
cmcm
22
))
((
cdCD
/A)/ A)
((
cdCD
/㎡)/ ㎡)
[실시예 14] 본 발명에 따른 화합물 14을 이용한 유기 발광 소자의 제작Example 14 Fabrication of Organic Light-Emitting Device Using Compound 14 According to the Present Invention
박막 두께가 150 nm인 ITO(인듐 주석 산화물) 투명 전극 라인을 갖는, 25 mm × 25 mm × 0.7 mm 크기의 유리기판을 증류수에서 10분 동안 초음파 세정하였다. 증류수 세정이 끝나면 아세톤, 증류수, 이소프로필알코올의 용제를 사용하여 기판을 순차적으로 10분씩 초음파세척하고 건조시켰다. 이어, 산소/질소 플라즈마를 이용하여 건식세정한 후, 투명 전극 라인을 갖는 유리 기판을 진공 증착 장치의 기판 홀더에 장착하고 투명 전극 라인이 형성되어 있는 면상에, 상기 투명 전극을 덮도록 막 두께 60 nm의 IDE-406(하기 구조, I사)막을 정공 주입층으로서 성막하였다. 다음에, IDE-406 막상에 막 두께 30 nm의 HT320 (tetrakis-N-biphenyl-4-yl-benzidine) (이하, HT320 막)을 정공 수송층으로서 성막하였다. 다음에, HT320 막상에 도판트로서 하기 구조의 BD-2을, 발광호스트로서 β-ADN(9,10-디(나프탈렌-2-일)안트라센)에 5%의 중량비로 증착하여 막 두께 20 nm의 발광층으로서 성막하였다.A 25 mm × 25 mm × 0.7 mm sized glass substrate having an ITO (indium tin oxide) transparent electrode line having a thickness of 150 nm was ultrasonically cleaned for 10 minutes in distilled water. After washing the distilled water, using a solvent of acetone, distilled water, isopropyl alcohol, the substrate was sequentially ultrasonically cleaned for 10 minutes and dried. Subsequently, after dry cleaning using oxygen / nitrogen plasma, the glass substrate having the transparent electrode lines was mounted on the substrate holder of the vacuum deposition apparatus, and the film thickness 60 was formed so as to cover the transparent electrodes on the surface where the transparent electrode lines were formed. A nm IDE-406 (following structure, I company) film was formed as a hole injection layer. Next, HT320 (tetrakis-N-biphenyl-4-yl-benzidine) (hereinafter referred to as HT320 film) having a thickness of 30 nm was formed on the IDE-406 film as a hole transporting layer. Next, BD-2 having the following structure as a dopant was deposited on the HT320 film at a weight ratio of 5% to β-ADN (9,10-di (naphthalen-2-yl) anthracene) as a light emitting host, and the film thickness was 20 nm. It formed into a film as a light emitting layer of.
상기 발광층 상에 본 발명의 화합물 14를 증착시켜 막 두께 20 nm의 전자 수송층으로 성막하였다. 이어, 그 위에 Liq (lithium quinolate)을 증착시켜 전자 주입층을 형성하였다. 이 Liq 막상에 금속 알루미늄을 증착시켜 금속 음극을 형성하여 유기 발광 소자를 제작하였다.
Compound 14 of the present invention was deposited on the emission layer to form an electron transport layer having a thickness of 20 nm. Subsequently, Liq (lithium quinolate) was deposited thereon to form an electron injection layer. Metal aluminum was deposited on the Liq film to form a metal cathode, thereby producing an organic light emitting device.
[실시예 15] 본 발명에 따른 화합물 131을 이용한 유기 발광 소자의 제작Example 15 Fabrication of Organic Light-Emitting Device Using Compound 131 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 131을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light emitting device was manufactured in the same manner as in Example 14, except that Compound 131 was used instead of Compound 14 as an electron transporting material in Example 14.
[실시예 16] 본 발명에 따른 화합물 137을 이용한 유기 발광 소자의 제작Example 16 Fabrication of Organic Light-Emitting Device Using Compound 137 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 137을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 137 was used instead of Compound 14 as an electron transporting layer material in Example 14.
[실시예 17] 본 발명에 따른 화합물 127을 이용한 유기 발광 소자의 제작Example 17 Fabrication of Organic Light-Emitting Device Using Compound 127 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 127을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 127 was used instead of Compound 14 as an electron transporting layer material in Example 14.
[실시예 18] 본 발명에 따른 화합물 138을 이용한 유기 발광 소자의 제작Example 18 Fabrication of Organic Light-Emitting Device Using Compound 138 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 138을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light emitting device was manufactured in the same manner as in Example 14, except that Compound 138 was used instead of Compound 14 as an electron transporting layer material in Example 14.
[실시예 19] 본 발명에 따른 화합물 132를 이용한 유기 발광 소자의 제작Example 19 Fabrication of Organic Light-Emitting Device Using Compound 132 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 132를 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 132 was used instead of Compound 14 as an electron transporting material in Example 14.
[실시예 20] 본 발명에 따른 화합물 135를 이용한 유기 발광 소자의 제작Example 20 Fabrication of Organic Light-Emitting Device Using Compound 135 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 135를 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 135 was used instead of Compound 14 as an electron transporting layer material in Example 14.
[실시예 21] 본 발명에 따른 화합물 139를 이용한 유기 발광 소자의 제작Example 21 Fabrication of Organic Light-Emitting Device Using Compound 139 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 139를 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 139 was used instead of Compound 14 as an electron transporting material in Example 14.
[실시예 22] 본 발명에 따른 화합물 128을 이용한 유기 발광 소자의 제작Example 22 Fabrication of Organic Light-Emitting Device Using Compound 128 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 128을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 128 was used instead of Compound 14 as the electron transporting layer material in Example 14.
[실시예 23] 본 발명에 따른 화합물 134를 이용한 유기 발광 소자의 제작Example 23 Fabrication of Organic Light-Emitting Device Using Compound 134 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 134를 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound 134 was used instead of Compound 14 as an electron transporting material in Example 14.
[실시예 24] 본 발명에 따른 화합물 136을 이용한 유기 발광 소자의 제작Example 24 Fabrication of Organic Light-Emitting Device Using Compound 136 According to the Present Invention
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 화합물 136을 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.
An organic light emitting device was manufactured in the same manner as in Example 14, except that Compound 136 was used instead of Compound 14 as an electron transporting layer material in Example 14.
[비교예 2] 화합물 ETM-1을 이용한 유기 발광 소자의 제작Comparative Example 2 Fabrication of Organic Light - Emitting Device Using Compound ETM-1
상기 실시예 14에서 전자 수송층 재료로서 화합물 14 대신에 하기 구조의 화합물 ETM-1를 사용하는 것을 제외하고는 실시예 14와 동일한 공정 하에서 유기 발광 소자를 제작하였다.An organic light-emitting device was manufactured in the same manner as in Example 14, except that Compound ETM-1 having the following structure was used instead of Compound 14 as an electron transporting material in Example 14.
상기 실시예 14 내지 24 및 비교예 2에서 제작된 유기 발광 소자의 전기 발광 특성 및 기초 물성 측정 결과를 하기 표 2에 나타내었고, 도 1에 실시예 14 내지 24 및 비교예 2에서 제작된 유기 발광 소자의 효율(cd/A)에 대한 휘도(cd/㎡)를 도시하였다.The electroluminescent properties and basic physical property measurement results of the organic light emitting diodes manufactured in Examples 14 to 24 and Comparative Example 2 are shown in Table 2 below, and the organic light emitting diodes manufactured in Examples 14 to 24 and Comparative Example 2 are shown in FIG. 1. The luminance (cd / m 2) versus the efficiency (cd / A) of the device is shown.
((
mAmA
/Of
cmcm
22
))
((
cdCD
/A)/ A)
((
cdCD
/㎡)/ ㎡)
상기 표 1 및 표 2에 나타난 바와 같이, 본 발명에서 개발한 재료의 발광 특성이 종래의 재료 대비 우수한 특성을 보이는 것을 확인할 수 있었다. 또한 본 발명에 따른 헤테로방향환 화합물을 전자수송층으로 사용한 유기 발광 소자는 발광특성이 뛰어날 뿐만 아니라 구동전압을 강화시켜줌으로써 전력효율의 상승을 유도하여 소비전력을 개선시킬 수 있었다.As shown in Table 1 and Table 2, it was confirmed that the light emission characteristics of the material developed in the present invention shows superior properties compared to the conventional material. In addition, the organic light emitting device using the heteroaromatic ring compound according to the present invention as the electron transporting layer not only has excellent light emission characteristics, but also enhances the driving voltage, thereby increasing power efficiency and improving power consumption.
Claims (6)
[화학식 1]
[상기 화학식 1에서,
Ar은 (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이고;
L1 및 L2는 서로 독립적으로 단일결합, (C1-C30)알킬렌, (C6-C30)아릴렌, (C3-C30)시클로알킬렌 또는 (C3-C30)헤테로아릴렌이고;
R1 및 R2는 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, -CR'=CR''R''', (C6-C30)아릴 또는 (C3-C30)헤테로아릴이며, 단 R1과 R2 중 반드시 하나 이상은 , 또는 이고;
L3 및 L4는 서로 독립적으로 단일결합 또는 (C6-C30)아릴렌이고;
R', R'', R''', R3 내지 R5는 서로 독립적으로 수소, (C1-C30)알킬, (C3-C30)시클로알킬, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고;
X는 O 또는 S이고;
상기 Ar의 아릴렌 및 헤테로아릴렌, L1 및 L2의 알킬렌, 아릴렌, 시클로알킬렌 및 헤테로아릴렌, 및 R1 내지 R5의 알킬, 시클로알킬, 아릴 및 헤테로아릴은 (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 및 하이드록시로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있고;
상기 헤테로아릴렌 및 헤테로아릴은 B, N, O, S, P(=O), Si 및 P로부터 선택된 하나 이상의 헤테로원자를 포함한다.]
An electron transport material represented by the following formula (1).
[Formula 1]
[In the above formula (1)
Ar is (C6-C30) arylene or (C3-C30) heteroarylene;
L 1 and L 2 are independently of each other a single bond, (C1-C30) alkylene, (C6-C30) arylene, (C3-C30) cycloalkylene or (C3-C30) heteroarylene;
R 1 and R 2 independently of one another are hydrogen, (C1-C30) alkyl, (C3-C30) cycloalkyl, -CR '= CR''R''', (C6-C30) aryl or (C3-C30) Heteroaryl, provided that at least one of R 1 and R 2 is , or ego;
L 3 and L 4 are independently of each other a single bond or (C6-C30) arylene;
R ', R'',R''', R 3 to R 5 independently of one another are hydrogen, (C1-C30) alkyl, (C3-C30) cycloalkyl, (C6-C30) aryl or (C3-C30) Heteroaryl;
X is O or S;
The arylene and heteroarylene of Ar, alkylene, arylene, cycloalkylene and heteroarylene of L 1 and L 2 , and alkyl, cycloalkyl, aryl and heteroaryl of R 1 to R 5 are (C1- C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C3-C30) cycloalkyl, (C1-C30) alkoxy, (C6-C30) aryloxy, (C6-C30) aryl, (C1- C30) alkyl (C6-C30) aryl, (C6-C30) ar (C1-C30) alkyl, (C3-C30) heteroaryl, (C1-C30) alkyl substituted (C3-C30) heteroaryl, (C6 (C3-C30) heteroaryl, mono or di (C1-C30) alkylamino, mono or di (C6-C30) arylamino, tri (C1-C30) alkylsilyl, di (C1-) C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, nitro and hydroxy may be further substituted with one or more selected from the group consisting of;
Wherein said heteroarylene and heteroaryl include one or more heteroatoms selected from B, N, O, S, P (= 0), Si and P.]
상기 Ar은 하기 구조에서 선택되는 것을 특징으로 하는 전자 수송 물질.
[상기 R11 내지 R21은 서로 독립적으로 수소, (C1-C30)알킬, 할로(C1-C30)알킬, 할로겐, 시아노, (C3-C30)시클로알킬, (C1-C30)알콕시, (C6-C30)아릴옥시, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴, (C6-C30)아르(C1-C30)알킬, (C3-C30)헤테로아릴, (C1-C30)알킬이 치환된 (C3-C30)헤테로아릴, (C6-C30)아릴이 치환된 (C3-C30)헤테로아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 나이트로 또는 하이드록시이고; a 내지 d는 서로 독립적으로 1 내지 4의 정수이고; e는 1 또는 2의 정수이다.]
The method of claim 1,
And Ar is selected from the following structures.
[The above R 11 to R 21 are independently of each other hydrogen, (C1-C30) alkyl, halo (C1-C30) alkyl, halogen, cyano, (C3-C30) cycloalkyl, (C1-C30) alkoxy, (C6 -C30) aryloxy, (C6-C30) aryl, (C1-C30) alkyl (C6-C30) aryl, (C6-C30) ar (C1-C30) alkyl, (C3-C30) heteroaryl, (C1- (C3-C30) heteroaryl substituted with alkyl, (C3-C30) heteroaryl substituted with (C3-C30) aryl, mono or di (C1-C30) alkylamino, mono or di (C6-C30) Arylamino, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, nitro or hydroxy; a to d are each independently an integer of 1 to 4; e is an integer of 1 or 2.]
하기 화학식 2 내지 8로 표시되는 것을 특징으로 하는 전자 수송 물질.
[화학식 2]
[화학식 3]
[화학식 4]
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
[상기 화학식 2 내지 8에서, L1 및 L2는 서로 독립적으로 단일결합, (C6-C30)아릴렌 또는 (C3-C30)헤테로아릴렌이고, 상기 L1 및 L2의 아릴렌 및 헤테로아릴렌은 (C1-C30)알킬 또는 (C6-C30)아릴로 더 치환될 수 있고; R1은 수소, (C1-C30)알킬, -CR'=CR''R''', (C6-C30)아릴, (C3-C30)헤테로아릴 또는 이고, 상기 R1의 알킬, 아릴 및 헤테로아릴은 (C1-C30)알킬 또는 (C6-C30)아릴로 더 치환될 수 있고; R11 내지 R20은 서로 독립적으로 수소, (C1-C30)알킬, (C6-C30)아릴, (C1-C30)알킬(C6-C30)아릴 또는 (C3-C30)헤테로아릴이고, 단, R11과 R12가 동시에 수소인 경우는 제외되고; R2는 , 또는 이고; L3 및 L4는 서로 독립적으로 단일결합 또는 (C6-C30)아릴렌이고; R', R'', R''', R3 내지 R5는 서로 독립적으로 수소, (C6-C30)아릴 또는 (C3-C30)헤테로아릴이고; X는 O 또는 S이고; a 내지 d는 서로 독립적으로 1 내지 4의 정수이다.]
The method of claim 2,
An electron transport material represented by the following Chemical Formulas 2 to 8.
(2)
(3)
[Chemical Formula 4]
[Chemical Formula 5]
[Chemical Formula 6]
(7)
[Chemical Formula 8]
[Formula 2 to In 8, L 1 and L 2 are each independently a single bond, (C6-C30) arylene or (C3-C30) heteroarylene, wherein the arylene and heteroarylene of L 1 and L 2 are (C1- C 30) alkyl or (C 6 -C 30) aryl; R 1 is hydrogen, (C1-C30) alkyl, -CR '= CR``R''', (C6-C30) aryl, (C3-C30) heteroaryl or Wherein the alkyl, aryl and heteroaryl of R 1 may be further substituted with (C 1 -C 30) alkyl or (C 6 -C 30) aryl; R 11 to R 20 are each independently hydrogen, (C 1 -C 30) alkyl, (C 6 -C 30) aryl, (C 1 -C 30) alkyl (C 6 -C 30) aryl or (C 3 -C 30) heteroaryl, provided that Except when 11 and R 12 are hydrogen at the same time; R 2 is , or ego; L 3 and L 4 are independently of each other a single bond or (C6-C30) arylene; R ', R'',R''', R 3 to R 5 are independently of each other hydrogen, (C6-C30) aryl or (C3-C30) heteroaryl; X is O or S; a to d are each independently an integer of 1 to 4.]
하기 화합물들로부터 선택되는 것을 특징으로 하는 전자 수송 물질.
The method of claim 3,
An electron transport material selected from the following compounds.
An organic light emitting device comprising the electron transport material according to any one of claims 1 to 4.
상기 유기 발광 소자는 제1전극; 제2전극; 및 상기 제1전극과 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어져 있으며, 상기 유기물층은 상기 전자 수송 물질이 포함된 전자 수송층을 포함하는 것을 특징으로 하는 유기 발광 소자.6. The method of claim 5,
The organic light emitting diode includes a first electrode; A second electrode; And at least one organic material layer interposed between the first electrode and the second electrode, wherein the organic material layer includes an electron transport layer including the electron transport material.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110060071 | 2011-06-21 | ||
KR1020110060071 | 2011-06-21 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130136926A Division KR20130131272A (en) | 2013-11-12 | 2013-11-12 | New material for transporting electron and organic electroluminescent device using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120140603A true KR20120140603A (en) | 2012-12-31 |
KR101376043B1 KR101376043B1 (en) | 2014-03-20 |
Family
ID=47906615
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120035373A KR101376043B1 (en) | 2011-06-21 | 2012-04-05 | New material for transporting electron and organic electroluminescent device using the same |
KR1020120062618A KR101435462B1 (en) | 2011-06-21 | 2012-06-12 | New material for transporting electron and organic electroluminescent device using the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120062618A KR101435462B1 (en) | 2011-06-21 | 2012-06-12 | New material for transporting electron and organic electroluminescent device using the same |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR101376043B1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015034140A1 (en) * | 2013-09-04 | 2015-03-12 | 희성소재(주) | Polycyclic compound containing pyrazole and organic light-emitting device using same |
KR101505059B1 (en) * | 2013-02-15 | 2015-03-25 | 주식회사 이엘엠 | Organic Light Emitting Material and Organic Light Emitting Diode Having The Same |
KR20150106506A (en) * | 2014-03-11 | 2015-09-22 | 삼성디스플레이 주식회사 | Condensed cyclic compound and organic light-emitting diode comprising the same |
KR20170065974A (en) * | 2015-12-04 | 2017-06-14 | 주식회사 엘지화학 | Hetero-cyclic compound and organic light emitting device comprising the same |
KR20180000621A (en) * | 2016-06-23 | 2018-01-03 | 삼성에스디아이 주식회사 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device |
US20180114921A1 (en) * | 2016-10-24 | 2018-04-26 | Novaled Gmbh | Organic Semiconducting Material Comprising an Electrical n-Dopant and an Electron Transport Matrix and Electronic Device Comprising the Semiconducting Material |
JP2018518036A (en) * | 2015-04-24 | 2018-07-05 | サムスン エスディアイ カンパニー, リミテッドSamsung Sdi Co., Ltd. | Compound for organic optoelectronic device, organic optoelectronic device, and display device |
JP2018129502A (en) * | 2016-10-24 | 2018-08-16 | ノヴァレッド ゲーエムベーハー | Organic electroluminescence device including redox-doped electron transfer layer and auxiliary electron transfer layer |
WO2020111081A1 (en) * | 2018-11-29 | 2020-06-04 | 保土谷化学工業株式会社 | Compound having azabenzoxazole ring structure and organic electroluminescent element |
JP2020525509A (en) * | 2017-06-30 | 2020-08-27 | トゥサン ソーラス カンパニー リミテッドDoosan Solus Co., Ltd. | Organic compound and organic electroluminescence device using the same |
CN112608279A (en) * | 2020-12-11 | 2021-04-06 | 东华大学 | Non-coplanar benzimidazole diamine and preparation method thereof |
KR20210154764A (en) * | 2020-06-12 | 2021-12-21 | 주식회사 엘지화학 | Heterocyclic compound and organic light emitting device comprising the same |
CN113831356A (en) * | 2021-09-24 | 2021-12-24 | 长春海谱润斯科技股份有限公司 | Compound containing condensed ring and organic light-emitting device thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461747B1 (en) | 1999-07-22 | 2002-10-08 | Fuji Photo Co., Ltd. | Heterocyclic compounds, materials for light emitting devices and light emitting devices using the same |
JP2005123164A (en) | 2003-09-24 | 2005-05-12 | Fuji Photo Film Co Ltd | Light emitting device |
US9523031B2 (en) | 2004-05-14 | 2016-12-20 | Idemitsu Kosan Co., Ltd. | Organic electroluminescent device |
JP5043404B2 (en) | 2006-11-20 | 2012-10-10 | キヤノン株式会社 | Heterocyclic compounds and organic light emitting devices |
-
2012
- 2012-04-05 KR KR1020120035373A patent/KR101376043B1/en active IP Right Grant
- 2012-06-12 KR KR1020120062618A patent/KR101435462B1/en active IP Right Grant
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101505059B1 (en) * | 2013-02-15 | 2015-03-25 | 주식회사 이엘엠 | Organic Light Emitting Material and Organic Light Emitting Diode Having The Same |
WO2015034140A1 (en) * | 2013-09-04 | 2015-03-12 | 희성소재(주) | Polycyclic compound containing pyrazole and organic light-emitting device using same |
KR20150106506A (en) * | 2014-03-11 | 2015-09-22 | 삼성디스플레이 주식회사 | Condensed cyclic compound and organic light-emitting diode comprising the same |
JP2018518036A (en) * | 2015-04-24 | 2018-07-05 | サムスン エスディアイ カンパニー, リミテッドSamsung Sdi Co., Ltd. | Compound for organic optoelectronic device, organic optoelectronic device, and display device |
US10797245B2 (en) | 2015-04-24 | 2020-10-06 | Samsung Sdi Co., Ltd. | Compound for organic optoelectronic element, organic optoelectronic element, and display device |
KR20170065974A (en) * | 2015-12-04 | 2017-06-14 | 주식회사 엘지화학 | Hetero-cyclic compound and organic light emitting device comprising the same |
US10672990B2 (en) | 2016-06-23 | 2020-06-02 | Samsung Sdi Co., Ltd. | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device |
KR20180000621A (en) * | 2016-06-23 | 2018-01-03 | 삼성에스디아이 주식회사 | Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device |
US20180114921A1 (en) * | 2016-10-24 | 2018-04-26 | Novaled Gmbh | Organic Semiconducting Material Comprising an Electrical n-Dopant and an Electron Transport Matrix and Electronic Device Comprising the Semiconducting Material |
JP2018121046A (en) * | 2016-10-24 | 2018-08-02 | ノヴァレッド ゲーエムベーハー | Organic semiconductor material including electrically n-dopant and electron-transporting matrix and electronic device including the same |
JP2018129502A (en) * | 2016-10-24 | 2018-08-16 | ノヴァレッド ゲーエムベーハー | Organic electroluminescence device including redox-doped electron transfer layer and auxiliary electron transfer layer |
JP2022058621A (en) * | 2016-10-24 | 2022-04-12 | ノヴァレッド ゲーエムベーハー | Organic semiconductor material containing electrical n-dopant and electron transport matrix, and electronic device containing semiconductor material |
JP2020525509A (en) * | 2017-06-30 | 2020-08-27 | トゥサン ソーラス カンパニー リミテッドDoosan Solus Co., Ltd. | Organic compound and organic electroluminescence device using the same |
US11917910B2 (en) | 2017-06-30 | 2024-02-27 | Solus Advanced Materials Co., Ltd. | Organic compound and organic electroluminescent device using the same |
WO2020111081A1 (en) * | 2018-11-29 | 2020-06-04 | 保土谷化学工業株式会社 | Compound having azabenzoxazole ring structure and organic electroluminescent element |
CN112805845A (en) * | 2018-11-29 | 2021-05-14 | 保土谷化学工业株式会社 | Compound having azabenzoxazole ring structure and organic electroluminescent element |
TWI822914B (en) * | 2018-11-29 | 2023-11-21 | 日商保土谷化學工業股份有限公司 | Compounds with azole ring structure and organic electroluminescent devices |
KR20210154764A (en) * | 2020-06-12 | 2021-12-21 | 주식회사 엘지화학 | Heterocyclic compound and organic light emitting device comprising the same |
CN112608279A (en) * | 2020-12-11 | 2021-04-06 | 东华大学 | Non-coplanar benzimidazole diamine and preparation method thereof |
CN113831356A (en) * | 2021-09-24 | 2021-12-24 | 长春海谱润斯科技股份有限公司 | Compound containing condensed ring and organic light-emitting device thereof |
CN113831356B (en) * | 2021-09-24 | 2022-12-27 | 长春海谱润斯科技股份有限公司 | Compound containing condensed ring and organic light-emitting device thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20130130591A (en) | 2013-12-02 |
KR101376043B1 (en) | 2014-03-20 |
KR101435462B1 (en) | 2014-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101376043B1 (en) | New material for transporting electron and organic electroluminescent device using the same | |
TWI721379B (en) | Pyrimidine derivatives and organic electroluminescence devices | |
JP6184867B2 (en) | Novel benzotriazole derivative and organic electroluminescent device using the derivative | |
TWI629257B (en) | Compound and organic electronic device using the same | |
KR101474713B1 (en) | New material for transporting electron and organic electroluminescent device using the same | |
KR101548686B1 (en) | New material for transporting electron and organic electroluminescent device using the same | |
CN106661024B (en) | Organic light-emitting compound and organic electroluminescent element using same | |
US20160149140A1 (en) | Compound for organic electroluminescent device and organic electroluminescent device including the same | |
EP2628729A1 (en) | Aromatic heterocyclic derivative, and organic electroluminescent element comprising same | |
KR101511954B1 (en) | New material for transporting electron and organic electroluminescent device using the same | |
KR20190120985A (en) | Heterocyclic compound and organic light emitting device comprising the same | |
WO2012001969A1 (en) | Aromatic amine derivative, and organic electroluminescent element comprising same | |
JP2012136498A (en) | BENZO[c]CARBAZOLE COMPOUND HAVING PYRIDINE-CONTAINING SUBSTITUENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | |
KR101891432B1 (en) | Amine based compound and organic electronic device using the same | |
TW202041502A (en) | Compound having benzazole ring structure, and organic electroluminescent device | |
JP6058531B2 (en) | Organic electroluminescence device | |
CN107778309B (en) | Quinoline derivative and application thereof | |
CN115322189B (en) | Spiro compound and application thereof | |
TW202030193A (en) | Compound having azabenzoxazole ring structure and organic electroluminescent element | |
WO2022173022A1 (en) | Compound and organic electroluminescent element using said compound | |
WO2020184379A1 (en) | Trisubstituted benzene compound having nitrogen-containing hetero ring in molecular terminus and organic electroluminescence element | |
KR101603884B1 (en) | New material for transporting electron and organic electroluminescent device using the same | |
KR20130131272A (en) | New material for transporting electron and organic electroluminescent device using the same | |
KR20160105318A (en) | Compound for organic electroluminescent device and organic electroluminescent device comprising the same | |
JP6306875B2 (en) | Organic electroluminescence device and electronic device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170913 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180312 Year of fee payment: 5 |